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1. Introduction 
1.1. Food Intoxication 
Foodborne intoxications are an enduring risk for public health and, therefore, the feasability 
of producing and consuming safe foods is considered as one of the major achievements of 
the last century. Over 200 known diseases are transmitted via food consumption [A1]. The 
spectrum of foodborne pathogens includes a variety of viruses, funghi and fungal toxins, 
chemicals, heavy metals, parasites, bacterial toxins and bacteria, whereas bacteria-related 
poisoning is the most prevalent. Only less than 20 different bacteria act as originators. Every 
year, Staphylococcus aureus, Salmonella, Clostridium perfringens, Campylobacter, Listeria 
monocytogenes, Vibrio parahaemolyticus, Bacillus cereus, and entero-pathogenic Escherichia 
coli are causing more than 90 % of all food poisonings that are related to known pathogens. 
These bacteria are mainly found in raw foods [A2, A3]. The Centers for Disease Control and 
Prevention [A4] in the United States (U.S.) is collecting data on foodborne disease outbreaks 
from all states and territories through the Foodborne Disease Outbreak Surveillance System 
to quantify the impact of these diseases on health. The estimated number of food-related 
diseases causes approximately 76 million illnesses, 323.914 hospitalizations and 5194 
deaths. Only 14 million illnesses, 60.000 hospitalizations and 1.500 deaths are caused by 
known pathogens, while unknown agents are responsible for the remaining numbers [A3]. 
Outbreak data reported internationally for source attribution were collected by Greig et al. 
[A5]. Based on sources of public reports published between 1988 and 2007, 4093 outbreaks 
are registrated and analyzed. According to this study, 2168 cases are allotted to the United 
States, 1287 to the European Union (EU), 246 to Australia and New Zealand, 208 to Canada 
and 184 to other countries. Based on a study and the European Commissions Rapid Alter 
System for Food and Feed, a total of 11.403 reports were published between July 2003 and 
June 2007 [A6]. Controlling bodies and guidelines are necessary due to the large number of 
outbreaks and their impact on public health. As food safety concerns consumers, food 
producers and regulatory agencies, widespread concepts through the whole feed and food 
chain - farm, transport, supply und consumption – are required to protect consumers from 
pathogen ingestion. Hazard Analysis and Critical Control Points is a systematic preventive 
approach to food and pharmaceutical safety which addresses physical, chemical, and 
biological hazards [A8-A10]. In Europe and the US a considerable number of research 
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projects aiming for new tools for food safety were funded. Most of the projects unify 
research and development topics such as improved analytical and sampling methods with 
modelling and the compilation of databases. Some projects have also a strictly food chain-
dominated structure. The large number of generated data sets affords refined statistical 
informatics. An introduction to practical biotraceability is given by Barker et al. [A11]. The 
high relevance attributed to consumer protection is documented by the substantial number 
of integrated EU projects such as BIOTRACER [A12]. It has 46 project partners from 24 
countries, including four International Co-operation countries and has a total budget of 15 
million Euro. Its objective is to provide tools and computer models for the improvement of 
tracing accidental and deliberate microbial contaminations of feed, food and bottled water.  
 
1.2. Protein Microarrays as Rapid Tools in the Food Production Chain 
Rapid and reliable detection methods are essential tools to process a large amount of 
samples that accumulate if a consistent food control shall be achieved. Customary 
microbiological methods such as cell culture techniques are often laborious and ineffective 
due to their incompatibility with the speed of the production chain and the distribution of 
food, its endurance, and the operational costs. Furthermore, bacterial strains can fail regular 
growth processes and lead to false analysis results. Quantitative polymerase chain reaction 
(PCR) is an accurate, rapid, specific, and sensitive method for detection of small amounts of 
pathogen Desoxyribonucleic Acid (DNA) in food samples. Unfortunately, DNA-based assays 
can only detect the presence of toxin producing organisms and do not quantify the amount 
of active toxins. On-line detection with PCR methods is also expensive and requires well-
trained personnel [A13]. Typical methods of instrumental analytical chemistry such as mass 
spectrometry, liquid chromatography, IR or UV/Vis spectrometry are powerful tools for a 
precise determination of pathogens, but they require time-consuming sample preparation 
and they are usually not transportable devices, thus  not applicable for on-line monitoring, 
e.g. in the production process. Sensor-based bioassays and microarray techniques are rapid 
and sensitive tools for on-line detection and automated processes control during food 
production and the supply chain. They can also be used in extensive research studies, mass 
tests, or to generate supporting data for modelling programs. The results can be used to 
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create new International Organization for Standardization or Deutsche Institut fuer Normung 
standards that are significant for a huge number of food producers.  
 
1.3. Aim of the Work 
This work is focusing on two further developments in the field of protein sensors and arrays 
for the detection of Staphylococcus aureus Enterotoxins SEA-SED and SEH in dairy products, 
especially in raw milk and raw milk cheese. 
The first project, a protein microarray for the detection of the Enterotoxins in milk and raw 
milk cheese, is part of the BIOTRACER project (European Union, 6th Framework Programme). 
The project consists of all levels of researcher, from mathematic modelers to scientific 
technicians and is splitted into several levels of research: Its objective is to provide tools and 
computer models for the improvement of tracing accidental and deliberate microbial 
contaminations of feed, food and bottled water. The newly developed protein microarray 
should be part of the tool construction of BIOTRACER creation of data for computer models. 
The protein microarray provides the possibility of being adapted into the production process 
control through its rapid processing time and the ability to measure more than just one 
analyte and/or sample at the same time. 
The second part of the work is the co-development of a SPR chip for the same procedure, 
the online-monitoring of failures in the production process of milk and cheese products.  
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2. Background 
In this chapter, background theory is presented to give a briefly overview of the key 
technologies used in this work. 
 
2.1. Labeling and Purification of Proteins 
The following chapters outline common strategies for labeling and purification of proteins. 
 
2.1.1. Labeling Techniques 
Direct protein detection and detection by fluorescence are two possibilities within multiple 
protein detection methods. Direct protein detection is possible via three aromatic amino 
acids: Tryptophane, Phenylalanine and Tyrosine. Their absorbance maxima are at 280 nm, 
257 nm and 274 nm and they possess intrinsic fluorescence within the range of 270 to 350 
nm. Unfortunately, the fluorescence intensities of Tryptophane and Tyrosine are much 
higher than those of Phenylalanine and the fluorescence of all three amino acids is highly 
temperature dependent [B1]. Therefore, proteins are better labeled by fluorescence dyes 
with functional reactive groups to overcome these disadvantages. During the last ten years, 
fluorescent labels attained enormous popularity. Their attraction is manifested in a 
multiplicity of commercially available fluorescence dyes at almost every wavelength. 
Companies like GE Healthcare [B2] or Invitrogen [B3], to name only the major ones supply a 
broad range of functionalized and therefore “ready-to-use” dyes. The main attraction of 
these dyes is originated in their high sensitivity after binding to a target. Its continuously 
signal generation is possible by regeneration of emitted photons. For assay development, 
the possibility of measuring multiple parameters becomes very attractive: fluorescence 
intensity, emission spectra, polarization or lifetime are only a small application window [B4, 
B5].   
An optimal fluorescent label should fulfill certain requirements and possess the 
characteristics as follows [B6]: 
- Stability of the fluorophore in water as well as in organic solvents. 
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- High molar absorbance of the fluorophore. 
- pH - independency of the fluorescence between pH 5-9 (physiological range). 
- High photostability is necessary. 
- At least one reactive group for coupling steps with the target under mild reaction 
conditions and medium temperature. 
- Weak fluorescence in its unconjugated form and high fluorescence when bound to the 
biomolecule of interest. 
- Large quantum yield to attain a high light intensity. 
 Now, a large number of labels that can be attached covalently are commercially available. 
Due to the regulations of the project „BIOTRACER“ and existing scanning equipment 
(Affymetrix428 Array Scanner from Affymetrix with lasers for excitation of Cy3/Cy5 and 
analogues  in wavelength), a dye of the cyanine dye group, Cy3, was chosen. The structure of 
the commercially available Cy3 NHS ester is presented in Figure 1. 
 
Figure 1. Chemical structure of Cy3 NHS ester (ready for covalent attachment)              
reproduced from [B2]) 
The cyanine dyes are long-wavelength dyes and exhibit absorption and emission 
wavelengths between 530 and 750 nm. The small Stokes´ Shift is characteristically for these 
dyes. The charged side groups are attached for excellent water solubility and furthermore, 
for prevention of self-association. Self-association is a conventional reason for tailing in the 
spectra, self-quenching and multi-exponential decay time [B5]. The analytes of interest 
within this work are natural existing proteins. As they are not detectable within the range of 
visible light, a covalently attached fluorescent label is used for detection. The covalent bond 
between analyte and label is formed via reaction of two different functional groups, each 
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located on one partner. The proteins used for labeling here are antibodies. They offer a 
range of functional groups at the side chaines as well as at the N and C terminus of the 
protein chain. Thiol groups and amino groups are the most commonly utilized binding sites 
for labeling. 
The thiol group of cystein is reacting in neutral or basic aqueous solution and therefore the 
iodacetamide, the maleimide and the disulfide exchange reaction are the methods of choice 
[B5, B7]. The labeling reaction schemes for protein thiol groups are presented in Figure 2. 
 
Figure 2. Maleimide labeling, iodacetamide labeling and disulfide exchange reaction of thiol 
groups on the protein (P: protein, F: fluorophore) (reproduced from [B7]) 
Protein labeling techniques using amino groups are the most appropriated ones [B5, B7]. 
They are presented in Figure 3. The most frequently used coupling reagents for amino 
groups are reactive esters, especially the N-Hydroxysuccinimidyl ester (NHS ester). 
Generally, labeling is done within a pH range of 8.5 to 9.5 and over a period of 15 minutes to 
hours. Labeling is proceeded in this pH range to prevent the hydrolysis of the active ester, 
which is a competing reaction. Unfortunately, active esters are often insoluble in water due 
to its uncharged nature. This requires organic solubilizers like dimethyl sulfoxide which can 
damage or denature the protein of interest. In addition, a change of global charge of the 
protein is induced via ester coupling and therefore, the solubility characteristics are 
changed. Isothiocyanates are modification reagents with intermediate reactivity. They are 
more stable in water than the reactive esters and can react optimally at pH 9-9.5. 
14 
 
Sulfonylchlorides are high reactive reagents. Although they are unstable in water, they form 
extremely stable sulfonamide bonds that can outlast amino acid hydrolysis. 
 
Figure 3. Labeling reactions of amino groups with NHS ester, isothiocyanate and 
sulfonylchloride (P: protein, F: fluorophore) (reproduced from [B7]) 
Carboxy acid and hydroxy groups of proteins play only a less relevant role for labeling. 
Carboxylated functional groups show low nucleophilicity in aqueous solutions, and therefore 
low reactivity. 
 
2.1.2. Purification Techniques 
Several clean-up methods for the labeled proteins were used in this work. A short overview 
is given as follows: 
Gel Filtration with Sephadex medium 
Gel filtration also called size exclusion chromatography is the simplest and mildest of all 
chromatography techniques [B8]. The separation is based on the differences in size. Group 
separation is used for the purification of labeled proteins. Sephadex, a trademark of GE 
Healthcare, is prepared by cross-linking a dextran with epichlorohydrin [B9]. There are 
different types, which vary in their degree of cross-linking and as a result in their selectivity 
for specific molecular sizes. Sephadex G25 medium, with a size exclusion of 5 kDa, is mostly 
used. It can be applied at high flow rate and low operating pressure. The liquid inside the 
particle is the stationary phase, whereas the liquid outside of the particle is termed mobile 
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phase. Molecules, like proteins, which are heavier and bigger than the exclusion size, do not 
enter the matrix. Consequently, they elute first, as they pass directly through the column. 
Small molecules, like dyes, which enter the matrix, elute in order of decreasing size.  
Filtering with the Millipore Amicon Ultra Filter Unit 
Amicon Filter Units use a 10 kDa cut-off membrane (Ultracel regenerated cellulose) to 
separate particles with a size smaller than 10 kDa [B10]. The membrane is integrated into a 
50 mL spin tube. The desired fractions are collected within the filter, the smaller fractions 
remain on the bottom of the tube. 
Clean up with the Melon Gel Spin Purification Kit  
The Melon Gel IgG Purification System [B11] purifies antibodies by removing non-relevant 
proteins under physiological pH allowing the antibody to flow through in a mild buffer 
suitable for storage and downstream applications. The system was developed to overcome 
the drawbacks of commonly used Protein A and G purification methods, which are labor-
intensive and requires harsh elution conditions to disrupt the affinity interaction. The gel 
eliminates the need for an elution step and uses a mild working buffer at physiological pH. In 
addition, the purified product is in a buffer free of primary amines and can be used directly 
in amine-reactive conjugation chemistries. The spin-column format is intended for single use 
and can be completed in less than 15 minutes. 
Clean up with the Nab Protein A Plus Spin Kit 
NAb Spin Kits [B12] are convenient for rapid, small-scale affinity purification of antibodies 
from a variety of sample types. Each pre-filled microcentrifuge spin column of the 
immobilized protein resin enables quick purification of 1-13 mg of IgG. Protein A is a 
bacterial protein that binds with high specificity to mammalian immunoglobulins (Ig). 
Immobilized types of this protein have been widely used for affinity purification of 
antibodies. Proteins A is binding to many of the same species and subclasses of IgG, although 
they have particular differences in affinity and binding capacity. Protein A is generally 
preferred for affinity purification of IgG from rabbit, pig, dog and cat.  
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2.2. Protein Microarray Formats and Technology 
In this chapter, the current state-of-art of protein microarray technology is presented, with 
focus on glass-based array formats.  An overview of protein array types and their description 
is given in Table 1. 
Table 1. Protein microarray types and their description. Adapted from [B17] 
Array type Description 
Antibody array Polyclonal or monoclonal antibodies are arrayed and used to 
detect and quantify specific proteins in a biological sample. An 
antibody array is effectively a parallel series of miniature 
immunoassays 
Antigen/reverse array The converse of an antibody array, this chip has immobilized 
antigens that are used to detect and quantify antibodies in a 
biological sample 
Functional array Purified proteins are arrayed on the surface and used to detect 
and characterize protein-protein, protein-DNA or protein-small 
molecule interactions 
Capture array Non-protein molecules that interact with proteins are 
immobilized on the surface. These may be broad capture agents 
based on surface chemistries or may be highly specific such as 
molecular imprinted polymers or oligonucleotide aptamers 
Solute array The potential next generation of arrays is to have nanowells 
containing coded microspheres or barcoded nanoparticles in 
solution 
 
Protein-binding can occur due to a number of possible capture agents, a short overview is 
given in Figure 4. 
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Figure 4. Overview of representative protein capture agents and detection methods for the 
development of protein-detecting microarray technology. Adapted from [B15]. (DNA: 
desoxyribonucleic acid, RNA: ribonucleic acid, SPR: surface plasmon resonance, MS: mass 
spectrometry, QCM: quartz-crystal microbalance) 
 
Antibodies are the most prominent capture agents due to their high affinity and specifity to 
the corresponding targets. Microarray-based enzyme-linked immunosorbent assay (ELISA) 
techniques have been developed as well to reduce sample consumption and to improve 
throughput. Introducing affinity tags to C or N terminus of recombinant protein enables 
fused-protein arrays and facilitates purification of proteins from complex mixtures. Several 
affinity fusions are available, for example six histidine residues (His tag), strep tag, 
Gluthathion-S-Transferase (GST), calmodulin-binding peptide, chitin-binding protein, 
maltose-binding protein or thioredoxin. Correlation between genotype and phenotype is 
established and libraries of DNA-encoded polypeptides/proteins can be produced and 
purified by molecular biology methods from E. Coli. Aptamers are oligonucleotides and have 
potential characteristics of both proteins and nucleic acids. They can be easily synthesized 
and amplified and can compete with antibodies in affinity to targets including proteins. A 
possible range of protein array applications is presented in Figure 5. 
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Figure 5. Overview of convenient protein microarray application types: sandwich ELISA (A), 
directly capturing hapten-labeled antigen (B), protein-protein interaction (C), serum sample 
probe for antibodies (D) or reverse-phase array (E) (adapted from [B13]) 
 
Protein microarrays are attractive for a range of applications: Antibodies can be arrayed as 
capture molecules for microspot sandwich ELISA-type experiments (Fig. 5A) or for directly 
capturing hapten-labeled antigens (Fig. 5B). Purified or recombinant proteins are used for 
studying protein-protein interactions (Fig. 5C) or for probing serum samples for antibodies 
(Fig. 5D). Reverse-phase arrays are applied for the profiling of hundreds of arrayed samples 
for the presence of a number of small antigens (Fig. 5E). Examples for surface chemistry 
classification and its agents [B15] are presented in Table 2.  
As Table 2 presents, various techniques are available and therefore a range of publications 
and books [B16-B18] exist. Within this work, the focus lies on 2D surfaces, especially from 
the non-specific category. Silanization with agents from this category is a common treatment 
for glass-based array applications. Beside these, polyacrylamide or nitro-cellulose coated 
slides are very popular. 
Due to the large number of possible applications and immobilization techniques, a more 
detailed overview is given in the next two chapters. 
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Table 2. Surface modifications for protein microarrays (adapted from [B15]) 
Surface type Category Surface (modified with) Capture agent (with) 
2D Nonspecific/ PVDF Functional group-independent 
 noncovalent Poly-L-Lysine Functional group-independent 
  Calixcrown 5-derivates Amines 
 Nonspecific/ Aldehyde Amines 
 covalent Epoxide Amines, Thiols 
  Succinimidyl ester Amines 
  Isothiocanate Amines 
  Photoaffinity reaction Functional group-independent 
 Specific/ Avidin Biotin tag 
 noncovalent Ni-NTA His tag 
  GST GST tag 
  Protein A/G IgG Fc region 
  oligoDNA oligoPNA 
 Specific/ Maleimide Thiol group 
 covalent Bromoacetyl Thiol group 
  Thioester Cysteine at N-terminus 
  Glyoxylyl group Aminooxy acetyl group 
  Semicarbazide Glyoxylyl group 
  Diels-Alder reaction  
  1,3-Dipolar 
cycloaddition 
 
Surface type Category Surface (modified with) Capture agent (with) 
3D  Agarose/Polyacrylamide  
  PDMS film  
  Nitrocellulose Functional group-independent 
  Gel pad  
  Supermolecular 
hydrogel 
 
PVDF: Polyvinylidenefluoride, NTA: Nitrilotriacetic Acid, PDMS: Polydimethylsiloxane, PNA: 
Peptide Nucleic Acid 
 
2.2.1. Arrays with 2-Dimensional Surface 
A silanization step is recommended when functionalizing of glass slides surfaces. Silanes 
form 2-dimensional self-assembled monolayers on the glass surface. 
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Cleaning 
Stored glass slides always have contaminated surfaces which affect silanization and create a 
non-uniform silane monolayer. Therefore, a cleaning step is recommended. Surfaces that are 
close to 100% hydrophobic are very attractive for silanization due to the fact that nearly all 
Si-OH groups are deprotonated. The contact angle of water is typically < 5°. Various cleaning 
methods exist from which the most important ones are explained a little more as follows. 
The most common methods are [B18]: Piranha solution, Hydrofluoric acid, Alkaline, 
Ultrasonication, UV/ozone and Laser. Piranha solution is a mixture of sulfuric acid and 
hydrogen peroxide and very effective in cleaning. The solution has always to be prepared 
freshly. Hydrofluoric acid is fast and effective against contaminants, but also highly toxic and 
damages the slide when applied for a longer period. Alkaline solution is effective in cleaning 
but requires time and longer incubation periods. Often, a 1:1:5-mixture of hydrogen 
peroxide (30% (v/v)), dissolved ammonia (32% (v/v)) and ultra-pure water is used. 
Ultrasonication in Ethanol cleans the surface with little disposal but is not as effective as 
Piranha solution. UV/ozone treatment is very fast and effective for removing thin film 
contaminants but ineffective in cleaning thicker layers. The laser cleans fast and effective but 
the slides are recontaminated if the slides are not stored under vacuum conditions. For my 
work, the alkaline solution mentioned above is used. 
Silanization Surface Chemistry 
Derivatized glass slides are adequate for immobilization of untagged proteins. They are 
bound via multiple interaction groups and attachment is proceeded in a variety of 
orientations so that different faces of the protein can interact with other molecules in 
solution. This random orientation decreases the number of protein interaction sites though 
inappropriate orientation or inactivation due to conformational change.  
The reactive coatings are major based on self-assembling techniques. Silane monolayers 
require hydroxylated surfaces as substrates for formation. The driving force of self-
assembley is the in-situ formation of polysiloxane which is connected to surface silanol 
groups. These organic films enable the biocompatibility of the surface and protect proteins 
from structural changes and denaturation in the immobilization step. Commonly used 
silanization reagents are presented in Figure 6. 
 Figure 6.  2D scheme of a polysilox
(X: terminal 
Silanization reagents: Aminopropyltriethoxysilane (APTES, 1), 
3-mercaptopropyltrimethoxysilane (MPTS, 2), glycidoxypropyltrimethoxysilane (GPTS, 3), 
Triethoxysilane undecanoic acid (TETU, 4), Bis
(HE-APTS, 5), 4-trimethoxysilylbenzaldehyde (6), 
glycidoxypropyltrimethoxysilanehexaethylene glyco
(reconstructed from 
Various techniques are available and therefore a range of publications exist. 
the SAM is influenced by temperature, reaction time, and 
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fabricate, store and use and results in good signal-to-noise ratios but are not applicable for 
printing very small proteins. Epoxy-coated slides are derivatized with epoxysilane and 
proteins are covalently attached via epoxide ring opening reaction. Surface amino, hydroxyl 
and thiol groups can react with this group, resulting in potentially higher binding efficiency 
than amino slides. Unfortunately, the epoxy ring is succeptible to moisture and therefore the 
slides have to be prepared moisture-free [B17]. 
 
Oriented Surfaces for Tagged Proteins 
Expressed proteins can be tagged at the amino or carboxyl terminus for site-specific 
attachment. This step encourages protein molecules to be oriented in a common direction 
away from the support surface and reduces structural distortion.  
Ni-NTA slides can be used with His-tagged proteins. This interaction is neither very strong 
nor very stable. Thus dissociation with washing or storage occurs. Chemicals like ethylene 
diamine tetraacetic acid or dithiothreitol effect the reaction, too. The biotin-avidine reaction 
is one of the strongest and most stable non-covalent interactions with a dissociation 
constant of 10-15M. Avidine is toxic to cells. Therefore, the protein is tagged with biotin and 
the support is functionalized with avidine. Furthermore, non-glycosylated steptavidin is an 
attractive coating agent, due to the possible non-specifity of the oligosaccharide component 
of avidine [B17]. 
 
2.2.2. Arrays with 3-Dimensional Surface 
3D surface slides have substantially deeper coating layers than the planar 2D surfaces which 
increase the surface and the binding capacity of the slide. 3D slides are difficult in 
manufacturing and therefore, commercially available slides are expensive. Polyacrylamide 
slides (Perkin Elmer Life Science or Xan Tec Bioanalytics) have a porous hydrophilic gel layer 
matrix of 20-30 mm in thickness which reduces the rate of evaporation and minimizes 
protein denaturation. On agarose slides, proteins are covalently immobilized to activated 
aldehyde groups in the layer. They are easy to prepare and enable higher sample load but 
uniformity and reproducibility is not sufficiently assessed. Nitrocellulose slides (15 mm layer) 
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are a good choice for maintain protein conformation and enable higher sample loading but 
need prolonged protein incubation time. They tend to have a high intrinsic background level 
because of light scattering, but this is compensated via higher sample load [B18]. Pictures of 
Nitrocellulose Slides and Nitrocellulose surface are presented in Figure 7. 
 
Figure 7. Fast Frame System on 16-pad Fast Slides and 3D structure of Whatman nitro-
cellulose (scanning electron microscopy, magnification 10000x). Adapted from [B13, B14]. 
 
2.3. SPR Technology and Chip Modification Techniques 
The physical phenomenon of Surface Plasmon Resonance (SPR) was first observed by Wood 
in 1902 and is applied in sensitive bio-detectors since 1983 [B19, B20]. Wood projected 
polarized light on a mirror with diffracting grating on the surface and observed a pattern of 
anomalous dark and light bands in the reflected light. This was the beginning of SPR. The 
physical interpretion of this phenomenon was initiated by Lord Rayleigh and refined by Fano 
[B21, B22]. The complete explanation was possible in 1968, when Otto and, in the same year 
Kretschmann and Raether, reported the excitation of surface plasmons. A first biomolecular 
application of SPR-based biosensors was reported by Liedberg et al. in 1983. [B23-B25] In 
the mid-80`s, Pharmacia Biosensor AB chose SPR as their leading platform technology for 
direct sensing of biomolecular interactions. They used the Kretschmann configuration which 
presents advantages in constructional tolerance of the liquid handling system. Light which 
comes from the prism, the higher refractive index medium, doesn`t pass through the liquid 
but is reflected at the sensor surface, covered with a metal layer. A thin gold layer was 
chosen as best inertial film for plasmon resonance. Furthermore, the gold layer was 
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modified with a self-assembling layer of long-chain thiols to which a hydrogel could be 
attached. Carboxylated dextrane was coupled to the surface providing a substrate for 
efficient covalent immobilization of biomolecules. Due to its thickness of 100 nm, the 
dextrane hydrogel is perfectly compatible with the evanescent field depth of about 200 nm 
[B26]. In 1990, Pharmacia Biosensor AB presented the first commercial SPR product, the 
Biacore instrument [B27]. This was the most sensitive, advanced, accurate, reproducible, 
reliable direct biosensor technique and SPR became the golden standard for transducer 
principles for measuring realtime biomolecular interactions. At the early 1990s, producers 
struggled to meet the standard set by Biacore. Since then, a range of new Biacore systems 
was established, which is still setting the standard.  
 
2.3.1 SPR Technology 
The Evanescent Wave 
 
Figure 8. Refraction of light at an incident angle at the interface of two materials with 
refractive indices n1 and n2 (adapted from [B26]) 
 
Before discussing SPR technology, it may be appropriate to visualize the evanescent wave, 
which is the center of SPR sensing, a little more. This is conveniently done by contemplating 
the phenomenon of total internal reflection.  
One has to watch the behavior of light at the interface of two separate media with differing 
refractive indices to understand this phenomenon. Light is refracted at the interface (Figure 
8) after Snellius´ Law: 
 
After supposition of refractive index n1>n2, total reflection is observed initiating from a fixed 
angle ac: 
 
However, light intensity is not decreasing rapidly to zero at the interface, it is decreasing 
exponentially with distance. The field in this perpendicular direction, the evanescent field, is 
reflecting the bound, non-radiative nature of surface plasmons. The exponentially intensity 
decay of the evanescent field with increasing distance is presented in Figure 9. 
 
Figure 9. Exponentially intensity decay of the evanescent field with increasing distance from 
the metal layer (adapted from [B26]) 
If the surface of a glass substrate is coated with a thin metal film, a part of the incident light 
can refract into the metallic film. Typical coatings consist of noble metals such as silver, gold, 
copper, titanium, and chromium. In this assembly, a second critical angle exists that is 
greater than the angle of total reflection. At this angle, the surface plasmon resonance angle, 
a loss of light appears and the intensity of reflected light reaches a minimum. This results 
from the interaction of the incident light with oscillation modes of mobile electrons at the 
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surface of the metal film. These oscillating plasma waves are called the surface plasmons. If 
this metal surface is coated by a thin layer of affinity ligands, the binding of biomolecules, 
e.g. proteins, causes a change of the refractive index. This is detected by a shift in the 
resonance angle. 
 
 
Figure 10. Scheme of the Surface Plasmon Resonance (left) and Kretschmann configuration 
for SPR sensors (right) [adapted from [B28] and [B29]) 
 
The frequently used Kretschmann configuration (Figure 10) is based on a metal film which is 
evaporated on one face of a glass prism. The light is coupled into the prism above the critical 
angle of total reflection, and the resulting evanescent wave penetrates the metal film. The 
plasmons are excited at the outside of the film. The angle of resonance is dependent on the 
refractive index of the surface. SPR reflectivity measurements can be used for the detection 
of specific molecular interactions of bound receptor molecules on the metal surface with 
their corresponding targets (e.g. DNA or proteins) [B30, B31]. The greatest attraction of SPR 
measurements is due to direct, label-free and real-time measurement of the refractive index 
at the surface. These sensors offer the measurement of low levels of biological and chemical 
compounds near the sensor surface. The sensor recognition of a biomolecular binding event 
happens when these molecules accumulate at the sensor surface and change the refractive 
index by replacing the background electrolyte. Water molecules have a lower refractive 
index than protein molecules [B26]. 
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Assay Process: from Buffer to Analyte 
A binding cycle observed with an optical biosensor is presented in Figure 11. Prior to the 
experiment, receptor molecules are immobilized on the surface via adequate coupling 
chemistry. At t=0 s, the cell containing the receptor is floated with running buffer to have a 
reliable baseline before capturing starts. At this point, active receptors are on the surface, 
ready for analyte binding. An analyte solution in running buffer is passed over the receptor 
at t=100 s. The refractive index of the medium adjacent to the surface is increasing after 
binding of analyte to the surface. This is monitored by increasing resonance signal. When 
analyzing this step of the binding curve, the observed association rate kobs is received. 
Furthermore, the association rate constant kass is determinable if the analyte concentration 
is noted. At the equilibrium, the amount of analyte that interacts with the receptor by 
association and dissociation is equal. The response level at this point is related to the active 
analyte concentration in the sample. At t=320 s, the analyte solution is replaced by buffer, 
the receptor-analyte complex dissociates. The dissociation rate constant kdiss can be 
obtained here. At t=420 s, a pulse of regeneration solution (high salt or low pH) is used to 
disrupt binding and regenerate the free receptor. The binding cycle is repeated several times 
with varying analyte concentration to receive a data set for global fitting to an adequate 
binding algorithm [B26, B28]. 
 
Figure 11. Binding cycle observed with an optical biosensor (adapted from [B28]) 
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Kinetics 
Interaction affinity can be calculated from the ratio of dissociation and association constant 
(KD = 1/KA = kdiss/kass) or by linear or nonlinear fitting of the response at the equilibrium of 
varying analyte concentrations. Again, buffer is injected to condition the surface for the next 
analysis circle. If regeneration is not complete, remaining mass causes an increased baseline 
level. Typical values for KA are within the range of 10
5-1012 L/mol, the values for KD within 10
-
5-10-12 mol/L. The dimensions for both rates are different and vary with stochiometry of the 
complex. Typical ranges show large variations and depend most on temperature. When 
starting, no product is present at the surface. At this point, the association rate is highest 
and dissociation rate is lowest. More and more of complex is produced and enhances the 
rate of dissociation during the process. Paralelly, the association rate might decrease. 
Equilibrium is reached when both rates are equal [B26, B28]. 
 
2.3.2. SPR Chip Modification Techniques 
Adhesion Layer and Self-Assembled Monolayers (SAMs) 
For SPR applications, it`s necessary to protect the sensitive bio-receptors from the 
uncompatible chip substrate material. Furthermore, functional groups for receptor 
immobilization were introduced by coating the substrate with a hydrophilic bioinert layer. 
Unfortunately, this layer would be washed away without the use of an adhesion layer. The 
adhesion layer provides a stable link between substrate and immobilization matrix and 
shields the substrate from buffer. Preferably, the thickness lies between 2 and 5 nm. Due to 
their chemical interness and easy functionalization options, gold or platin are used. Within 
this work, a gold layer is used. Alkyl derivates of thiol groups with chains lengths of 4-10 
carbon atoms assemble spontaneously on golden SPR chips under formation of high packing 
density self-assembled monolayers. Typical derivates are 16-hydroxyhexadecane-1-thiol and 
16-Mercaptohexadecanoic acid. The adsorption is done in 300 mM ethanolic solutions for 8-
24 h. Long incubation time guarantees more ordered and packed SAMs.  
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Coupling Chemistry for Receptor Immobilization 
Now, the receptors can be coupled to the SAMs. Therefore, coupling chemistry is 
approached. In general, four different groups of coupling approaches exist:  adsorption, 
covalent activation chemistry, electrostatic immobilization and directed immobilization. The 
most prominent examples of coupling variants are presented in Figure 12 and 13. 
 
Figure 12. Coupling methods for receptor immobilization: covalent attachment (R = residue)            
(adapted from [B28]) 
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Water-soluble 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC)-mediated activation of 
a carboxymethylated support is presented in Fig. 12 box (a). The resulting reactive NHS ester 
can be coupled directly with amino residues of the receptor. Further derivatization with 
sulphydryl-reactive reagents allows reaction with free surface thiols for reversible disulfide 
linkage. Amino-presenting surfaces can be processes with commercially available bifunc-
tional linkers to effect coupling with free amino or sulphydryl groups on the receptor (Fig. 12 
box (b)). Surfaces that are derivatized with salicylhydroxamic acid can be used to produce 
reversible complexes with phenyldiboronic acid-activated receptors (Fig. 12 box (c)). 
 
Figure 13. Coupling methods for receptor immobilization: non-covalent attachment     
(adapted from [B28]) 
 
Biotin- or streptavidin-presenting surfaces are applicable for biotinylated receptors (Fig. 13 
box (a)). Monoclonal antibodies can be covalently attached to a solid support by means of 
amine coupling. Epitope-tagged or fusion proteins are reversibly and directly coupled to the 
surface through antibody antigen interactions (Fig. 13 box (b)). Metal-coordinating groups 
such as iminodiacetic acid and NTA are used for immobilization of 6-His- and 10-His-tagged 
receptors (Fig. 13 box (c)). 
Within this work, EDC coupling chemistry is used and will be presented more in detail here. 
The receptors, Staphylococcal enterotoxins A and B, are proteins and build stable covalent 
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bound with the modified SAM. Due to the carboxyl groups on the surface of the SAM, it is 
not reactive with amino groups yet, so activation with 1-Ethyl-3-(3-dimethyl-aminopropyl) 
carbodiimid is recommended. EDC is very reactive and highly water soluble as hydrochloride. 
The EDC coupling mechanism is presented in Figure 14. 
 
Figure 14. EDC protein coupling mechanism (reproduced from [B7]) 
Unspecific binding of proteins to polar surfaces (carboxy groups) is prevented via blocking 
step. EDC is highly reactive, so toxins can react with each other or EDC is inactivated with 
water. Binding of toxins to the surface changes conformation and therefore influences 
biological activity. Failed recognition of the antibody can result from this. 
 
Figure 15. Sensorgram of a receptor immobilization (adapted from [B28]) 
A typical SPR coupling experiment with EDC/NHS, a receptor/ligand and ethanol for blocking 
free binding sites is presented in Figure 15 [B26, B28]. 
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2.3.3. SPR Assay Types 
Common immunoassay formats are presented in Figure 16. 
 
Figure 16. Common Immunoassay Formats for SPR (adapted from [B28]) 
 
(a) Direct Assay 
Within this assay type, antibodies (= receptor) directed against the antigen are located on 
the surface. The sample solution, which contains the analyte, is incubated with the sensor 
surface. The signal increase is antigen-binding dependend and is directly correlated with the 
analyte concentration in the sample. Direct assays can also act with antigen-modified 
surfaces for the detection of binding the specific antibody. 
 
(b) Competition Assay  
Competitive assays are optimal for the recognition of small antigens with low weight that do 
not generate an acceptable signal while accumulating at the surface. Herein, specific 
antibodies are immobilized on the sensor surface. The sample solution contains the antigen 
and antigen conjugate. Due to its high molecular weight, the conjugate enhances an SPR 
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angle shift. The mixture of antigen with its corresponding antibody is incubated with the 
surface. The signal difference between a reference sample (only conjugated antigen) and the 
sample solution indicated the amount of antigen in the sample. High antigen concentrations 
produce low signal (less conjugate bound). Signal maximum is achieved when no free analyte 
is present. In competitive immunoassays, the conjugated antigen is often attached to a large 
refractive index label (latex bead or gold nanoparticle) loaded with antigen. 
 
(c) Inhibition Assay 
In this format, target antigens are immobilized on the sensor surface. The sample solution 
which contains the antigen is mixed with specific antibodies in excess and incubated with the 
sensor surface. Antibodies are binding to antigen that is bound on the surface and in 
solution. Signal difference between a blank sample without antigen and the sample solution 
indicates the antigen amount in the sample. Herein, high antigen concentrations in sample 
result in low signals, resulting from a less number of antibodies to bind. The binding is 
detected directly, due to the high molecular weight of antibodies. 
 
(d) Sandwich Assay 
In sandwich assays, antibodies against the analyte are immobilized on the array surface for 
capturing the analytes after sample incubation. A secondary antibody is binding specifically 
with either the antigen or the primary antibody. The antigen is captured by a sandwich of 
two antibodies. A high affinity capture antibody is required here. The increase in signal is 
proportional to the amount of antigen in the sample. The surface is washed with buffer 
followed by injection of a secondary antibody. The binding process can be monitored by the 
high weight of the secondary antibody. For further enhancement, antibody conjugates with 
colloidal gold or latex particles as refractive index label can be applied. 
 
SPR: Adavantages of a Label-Free Method for the Application of Real Samples 
The adavantages of SPR in combination with food samples are presented as follows. 
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2.4. Staphylococcus Aureus Enterotoxins 
Foodborne Diseases (FBD) are defined as “diseases of toxic or infectious nature caused by, or 
thought to be caused by the consumption of food or water” (World Health Organization, 
[B32]). Over 250 FBDs have been described and the symptoms vary widely depending on the 
etiological agents. Diarrhea and vomiting are the most common symptoms. Among the FBDs, 
there are 2 different types: food-borne infections and food-borne intoxications/poisoning. 
The infections are caused by many different disease-causing pathogen agents that can 
contaminate food whereas intoxications are caused by poisonous chemicals or other 
harmful substances that are present in food [B33]. In case of infections, the food is the 
carrier of pathogen bacteria, a reproduction within the food is not necessary. Transgression 
of the infection barrier induces the break-out of the infection. The barrier is species-
dependent. Typical examples are salmonellosis and infections with Campylobacter, Yersinia 
and E. Coli. In case of intoxications, bacteria are reproduced in the food. Toxins are 
biosynthesized from their metabolic products with the help of chemical substances out of 
food. Outbreak of illness is given after the consumption of toxin-containing food, with or 
without living bacteria. Typical examples are Staphylococcus aureus, Bacillus cereus and 
Clostridium perfringens. The toxins are preformed in the food, and so the intoxications have 
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short incubation times/onsets of few hours (S. aureus: 15-30 minutes!). In most cases, the 
symptoms leave after at least 24 h [B34]. Outbreaks are frequently traced back to situations 
where food preparers did not comply with hygiene and safety regulations or to incidences 
where food, that has to stay freezed, was exposed to room temperature. Unfortunately, 
alignments containing enterotoxins usually taste, smell and look unsuspicious and not 
adulterated [B35].  
 
2.4.1. Staphylococcus aureus - General Information 
Staphylococcus aureus affiliates to the species “Staphylococcus” and therefore to the family 
of Micrococcaceae. It was found in 1883 from Sir Alexander Ogston which gave him the 
name due to the winegrape-like cluster look. S. aureus can be differed from other 
Staphylococcus types with the coagulase test, where it is coagulase-positive. Staphylococcus 
aureus is a non-motile, gram-positive and catalase-positive coccus bacterium with a 
diameter of 0.5-1.5 mm. The cocci are arranged in grape-like clusters, as singles, as pairs or in 
short chains. The cell wall is resistant to lysozyme and sensitive to lysostaphin which cleaves 
the pentaglycin brigdes of Staphylococcus spp. Some strains are capable of building toxins 
and unlike to other bacteria, it is non-spore forming. S. aureus is characterized as fast-
growing in aerobic or non-aerobic conditions on a broad spectrum of growing media. The 
colonies are clearly separated and smooth after 18-24 h of growing at 35°C. The golden 
pigmentation, originated from carotinoides, is visible in most cases. S. aureus possesses the 
capability to grow at high salt concentrations (5-15% NaCl), between 7-48.5° C (optimum 30-
37° C), at a pH between 4.2 and 9.3 (optimum 7.5) and builds carotinoide pigments. 
Furthermore, glucose can be dissipated under formation of lactid acid [B33, B34]. It grows 
on simple growing media, under high temperatures (45°C) and preferentially in foods with 
low water activity (cooked or strong salted food), where it outcompetes other 
microorganisms [B36, B37]. The bacterium is disseminated ubiquitarily, man and animals 
possess it on the mucosa of nose and mouth without getting ill. Thus, contamination paths 
are often irreproducible. More, it belongs to the resident flora and washing hands does not 
improve the situation. Staphylococcus aureus is obtained as one of the major agent for food 
intoxications and has clinical importance due to the ability of building heat-stable 
enterotoxins and enzymes. It is an important pathogen because of toxin-mediated virulence, 
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invasiveness and antibiotic resistance. Furthermore, it is a major cause of nosocomial 
infections as well as community-acquired diseases. The spectra of infections range from 
furuncles and pimples to toxic shock syndrome and sepsis, most of which depend on 
multiple virulence factors. But some infections like food poisoning rely only on one single 
type of factor. Its prevalence in food is considered as a sign for absent hygiene. Illnesses due 
to these toxins are real intoxications and marked via acute gastroenteritis. One to six hours 
after ingestion, persistent vomiting occurs. Diarrhea, abdominal cramps, headache, muscle 
cramps and sweating can appear, too. Normally, remission is achieved in less than 24 h, only 
the elderly and children have to be very careful [B34, B36, B37]. 
 
2.4.2. Staphylococcal Enterotoxins - A characterization 
Staphylococcal Enterotoxins (SEs) are proteins providing high water and saline solubility. 
Their molecular mass ranges between 20-30 kDa with a pI between 5 and 8.6. The major 
biochemical characteristics are listed in Table 3. Enterotoxins comprise single polypeptide 
chains with a high content of lysine, trypsine, aspartic acid and glutamic acid. The secondary 
structure is built of a-helices and ß-sheets. Crystal structure studies monitored that all 
enterotoxins possess similar 3-D structures. They are ellipsoid and comprises two domains, A 
and B. Domain B has, at its end, the characteristic cystine loop with a disulfide bridge. The 
cystine loop is required for proper conformation and probably involved in the emetic 
activity. The larger domain A comprises C- and N- terminus. Both domains are linked 
together with a chain of a-helices [B33, B35]. 
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Table 3.                                                                                                                             
Biochemical characteristics of the staphylococcal Enterotoxins (partially adapted from [B34]) 
SE Type Molecular mass (kDa) Gen size (bp) Isoelectric point 
SEA 27.100 774 7.26 
SEB 28.336 801 8.6 
SEC1 27.531 801 8.6 
SEC2 27.589 801 7.0 
SEC3 26.900 801 8.2 
SED 27.300 777 7.4 
SEE 26.900 774 7.0 
SEG 27.042 777 5.7 
SEH 25.210 726 5.7 
SEI 24.928 729 not defined 
SEJ 28.5651 806 8.651 
SEK 25.539 729 6.5 
SEL 24.5931 723 8.661 
SEM 24.8421 722 6.241 
SEN 26.0671 720 6.971 
SEO 26.7771 783 6.551 
SEP2 not defined 782 not defined 
SEQ 28.200 728 7.5 
SER2 bigger than 27.000 779 not defined 
SEU2 not defined 785 not defined 
1: Molecular mass and isoelectric point are postulated due to gen size and gen sequence; 2: Existence 
postulated due to molecular biology tests, toxin not realized/sequenced 
 
Staphylococcal enterotoxins cause severe gastroenteritis with symptoms like diarrhea and 
vomiting within one to six hours after ingestion and act as superantigens that stimulate non-
specific T-cell proliferation [B38]. Staphylococcal enterotoxins can act undesirably in food 
due to their extreme resistance and stability. In general, these proteins are resistant to 
chymotrypsine, papaine and rennin and keep their activity in the digestive tract after 
ingestion. The inactivation of SEB with pepsin affords pH values ≤2! Furthermore, the toxins 
are insensitive to freeze-drying and irradiation. The most important fact concerning food 
safety is their extreme heat-stability. The bacteria itself is inactivated at high temperatures, 
in contrast to the toxins [B39-B41]. Thus, prevention of bacteria growth at production and 
storage processes is recommended! Their physical and chemical characteristics were 
summarized by Jay. [B42] Detection and analysis of enterotoxin existence was started with 
S. aureus strains from the first food intoxications. This method originated the first three 
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toxins, SEA-SEC. New SE types were identified from data of genome sequence analyses. A 
comparison of sequence homologies is presented in Figure 17. 
 
Figure 17.                                                                                                                             
Percentage of amino acid identity in different enterotoxin types (adapted from [B33]) 
 
Only SEA-SEE and SEH could be produced as pure proteins and identified as toxins. Beside 
these classic types a new selection, named SEG-SEU, was found. Among these, SEA-SED are 
the most common food pathogens. Particularly, enterotoxin A is involved in most of the 
disease outbreaks, whereas SEB is a potential bioterrorism agent. Minimal toxic dose data is 
quite rare and exists only for prominent representants of the group. The corresponding oral 
dose for SEA, SEB and SEC1 is specified by less than 1 mg/kg for humans. SED, SEE and SEH 
are less toxic, 10-30 mg/kg are afforded for monkeys. SEA is the most toxic one, all other 
types are less toxic [B33, B34].  
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2.4.3. Formation and Prevalence of Enterotoxins in Food 
 Toxin production in food requires two parts. On the one hand, the food must be 
contaminated with toxin-producing S. aureus and on the other hand, special factors are 
needed to reach the bacterial count for the production. There are a lot of environmental 
factors that affect staphylococcal enterotoxin production: nutritive value, pH, water activity, 
temperature, oxygen content and interactions with other microorganisms. There is a 
complex interaction of all factors within the food, so detection of a simple and major factor 
is really difficult [B34]. Concretely, glucose inhibits production of toxins, especially for SEB 
and SEC. Probably, the drop in pH, due to the glucose metabolism, induces the inhibition. 
The production of toxins has its optimum in neutral pH, decreases in acidic pH and is 
inhibited in pH below 5. The inhibition effect of acidic pH is increased by high salt 
concentrations. No more production is achieved at salt concentrations above 12%, with no 
dependence on pH. Furthermore, alkaline pH decreases the production of SEB-SED. In 
addition, Staphylococcus is very sensitive to competing microflora [B33]. As example, a level 
of 106 S. aureus/g food must be reached in cheese to build an adequate amount of 
enterotoxins. The incidence of enterotoxins is much more determined via bacterial counts 
than via progression. The higher bacterial counts at the beginning of the cheese process, the 
more probable is the overcome of competitive parameters. Concerning cheese, long storage 
times are unfavorable for the prevention of bacterial reproduction. Unappropriate cooling or 
high water contents of cheeses are disadvantageous, too. Competitive inhibition of S. aureus 
through surrounding microflora prevents large reproduction of the bacteria and therefore 
toxin production. Cheese starting cultures contain milk acid bacteria which build lactose 
from milk acid. This process decreases the pH value and inhibits staphylococcal growth.  
Concentration, activity and composition of the starting culture are significant for the 
progression of Staphylococcus aureus counts. Staphylococcal enterotoxins are 
predominantly generated in the post-exponential growth phase of the bacteria. Around 40-
50% of all strains from humans are capable of building enterotoxins [B34]. Commercially 
available detection kits are listed in Table 4.  
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Table 4. Commercially available test kits for Staphylococcal enterotoxins in food 
TEST TYPE BOMMELI 
( Dr. 
Bommeli 
AG, Bern) 
RIDASCREEN 
(R-Biopharm 
GmbH, 
Darmstadt) 
TECRA 
(Tecra 
Diagnostics) 
TRANSIA 
(Microgen 
Bioproducts, 
Camberley) 
SET-RPLA 
(Oxoid, 
Basingstoke) 
VIDAS 
(BioMerieux, 
Nürtingen) 
Detectable 
toxins 
A - D (H) A - E A - E A - E A - D (E) A - E 
Differentation 
toxins 
Yes Yes No No No No 
Sensitivity High High Medium Medium Low Low 
Specifity High High Low Low High Medium 
Test time (h) 24 3 4.5 1.5 - 2 16 1.5 
Complexity 
Test 
High Medium Medium Medium Low Automated 
Complexity 
Extraction 
High Medium Medium Medium Low Low 
Costs Medium High Medium High Medium High 
Tests per kit 10 12 12 - 44 10 - 40 20 30 
Format ELISA ELISA ELISA ELISA RPLA ELISA 
 PS - balls MT - Strip MTP Tube  MT - Strip 
LOD  
 (ng / g) 
0,6 [B43] 
0,1 - 
1[B34] 
0,5 – 0,75 
[B44] 
0,2 - 0,7 
[B47] 
1 – 3 [B45] 
1 [B46] 
> 0,6 [B43] 
 
4 [B43] 
1 [B48] 
0,05 - 0,1 
[B49] 
 
 
Due to high cost per test and the insufficient separation specifity for different types of 
toxins, additional tests are necessary. 
 
2.5. Fluorescence: an Application in Protein Microarrays 
Protein microarray applications demand high detection sensitivity, especially the ability of 
differentiating potentially low analyte signals from the background. The surface coating 
should contribute only minimally to the intrinsic background of the substrate. A number of 
detection strategies are used for imaging protein microarrays, but the majority of 
laboratories currently rely on fluorescence-based scanners. All available microarray scanners 
are configured to detect the most conventional fluorescent dyes for microarray analysis, Cy3 
and Cy5. Certainly, most of them are additionally equipped with other lasers and filters to 
enable the use of a wider range of dyes. In this work, an Affymetrix 428 array scanner with 
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two appropriate lasers for Cy3 and Cy5 is used. Fluorescence intensity emission can be 
detected with the help of photomultiplier tubes within the system. 
For the analysis of the appropriate spot intensity, two possibilities are given: total signal 
intensity and the mean signal intensity. The total signal intensity is the sum of all intensity 
values of all analyzed pixels in the spot area. Unfortunately, total signal intensity is sensitive 
to the variation in the amount of biological material which is deposited on the spot, 
contamination and anomalies in the image processing operation. These problems occur 
frequently, so the total intensity may not be an accurate mode of measurement analysis. 
The mean signal intensity is the average intensity of the signal pixels. This parameter has 
certain advantages over the calculation of the total intensity. Often, spot size is correlated to 
the concentration of the sample in the wells during the spotting process. Measurement of 
the mean value decreases the error which is caused by the variation in the amount of 
immobilized decoy deposited on the spot. Advanced image processing permits accurate 
distinction of contamination pixels from signal pixels, so the mean value method should be 
the parameter of choice [B17]. 
When using older laser scanners, the planarity of the entry funnel and the measuring plane 
is often a problem.  This results in differentiating scanner plots of the same array type. 
Furthermore, a comparison of two or more different arrays is only possible with exact slide 
measurement geometries. 
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3. Microarray Surface Preparation 
This chapter describes the cleaning, preparation and quality control of the homemade 
microarray slide silane surfaces. 
In the following chapters, anti-SEX (X = A, B, C, D or H) is replaced by <SEX>. 
 
3.1. Control of Cleaning via Contact Angle 
Microarray surfaces were cleaned prior to silanization, followed by sessile drop contact 
angle measurement as quality and efficiency control. Water is used as measurement liquid. 
A repertory of methods is published in [C1].  
The contact angle is specific for any given system. If a liquid is strongly attracted to a solid 
surface (e.g. water on very hydrophilic substrate), the droplet is completely spread out and 
the angle is close to 0°. Less hydrophilic surfaces will have contact angles up to 90°. Water 
exhibits angles of 0-30° on many hydrophilic surfaces. On hydrophobic surfaces, contact 
angles are above 90°. Before cleaning, contact angles were higher than after the process. 
This monitors the increasing hydrophilic character of the cleaned slides which is required for 
silanization. 
The results of the cleaning step are presented in Table 5. 
Table 5. Contact angles for H2O before and after the cleaning step 
Slide type Contact angle  
Θb / [°]  
(before cleaning) 
Comment Contact angle 
Θa / [°]  
(after cleaning) 
Comment 
Plain glass 19,92 ± 11,04 inhomogenous 
distribution 
12,25 ± 3,7 relatively 
homogenous 
distribution 
Hydrophobic 
pattern slide glass 
63,75 ± 3,75 - 32 - 
 
All contact angles are higher than expected from literature [C1], which might be caused from 
to short cleaning time. 
 
43 
 
3.2. Control of Silanization via Contact Angle Measurement 
Four silanes were applied for surface treatment: 
 
Figure 18. Common glass slide silanization reagents (reconstructed from [B17]): 
Aminopropyltriethoxysilane (APTES), 3-mercaptopropyltrimethoxysilane (MPTS), 
glycidoxypropyltrimethoxysilane (GPTS). 
The silanization step is proceeded under nitrogen atmosphere. For APTES, contact angles of 
55-63° in water [C2-C4] are published, whereas GPTS-coated surfaces exhibit angles around 
57° [C5]. Contact angles are measures with the sessile drop method after silanization. The 
results are outlined in Table 6 and Figure 19. 
 
Table 6. Contact angle values for H2O after the silanization of plain glass slides and 
hydrophobic patterned slides with various silanization agents 
Silanization 
method 
Reagent Parameters Contact angle θs / 
[°] 
A 100 % GPTS 3h, RT 62,56 ± 5,57 
B 2.5 % GPTS 1h, RT 56,83 ± 3,88 
C 100% APTES 2h, RT 39,33 ± 4,01 
D 5% APTES 1h, RT 56,48 ± 4,81 
E 1% MPTS 1h, RT 60,41 ± 3,67 
F 100% Aldehyde silane 2h, RT 63,50 ± 4,01 
G 2% Aldehyde silane 1h, RT 57,31 ± 6,90 
H 2% APTES 3h, 115°C, N2 66,38 ± 1,84 
Nexterion Slide E  
(NEX) 
- published: 57 51,29 ± 1,11 
Erie Super Amino 
Slide (ERA) 
- published: 40 ± 5 41,30 ± 3,60 
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Figure 19. Contact angle data for different slide modification types 
Nexterion Slide E and Erie Super Amino Slides were used as standardization for the contact 
angle measurement method to guarantee correct proceeding. For MPTS and aldehyde slides, 
there was no contact angle data available in literature. Due to the high standard deviation of 
the angle (F, G) and high costs for the silane, aldehyde silane was no longer used for further 
experiments. MPTS covered slides (E) require a linker for binding antibodies or toxins, which 
prolonges the processing time of the array and harbors the risk of random alignment. As 
expected, methods using undiluted silane show similar values for epoxy- and aldehyde 
groups (A and F), independent of incubation time. GPTS slide A exibits a contact angle above 
the cited literature ([B5] and NEX literature) of 57° and a relatively high standard deviation. 
This assumes that a 100 % solution of silane is not the appropriate choice. GPTS slide B is 
according to the reference of 57°. Amino slide C is analog, the value lies near the ERA 
reference and literature of 40°. Herein, a 100% solution of APTES is applicable. Slides D and 
H are near the expected values of 56-63°. The disadvantage of using APTES is its rapid aging 
in liquid as well as on the array. Furthermore, a linker is needed (see MPTS). Therefore, GPTS 
slides are chosen as preferred surface. GPTS -modified slides are best to use 3 months up to 
1 year after silanization, so long-time storage is applicable. All further experiments are 
proceeded with a variance in number H, 3 h at 115° C with 2% GPTS (instead of APTES) in dry 
toluene in N2 atmosphere. 
 
45 
 
3.3 Control of Immobilization via Fluorescence Detection 
Control is proceeded with a Cy3-labeled staphylococcal antibody array of ascending toxin 
layer concentration rows (from left to right each) in Figure 20. 
 
Figure 20. Quality control of silanization with increasing concentrations of competitive toxin: 
SEA (left) and SEB (right) (0-40 ng/mL, in columns from left to right) 
 
All columns have identical concentration and so they represent the quality level of the 
silanization. With exception of certain surface defects, the quality of the slides (standard 
deviation: 8-15%) is acceptable. 
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4. Labeling Staphylococcus aureus Enterotoxin Antibody 
This part of the thesis focuses on the fabrication of the detector elements – the 
fluorescently-labeled antibodies of Staphylococcus aureus Enterotoxins. These are applied to 
quantify the level of competitive toxins in sample and standard solutions. 
 
4.1. Targets: GST- and Staphylococcus aureus Enterotoxin (A-D and H) Antibodies 
For working efficient and saving money, anti-Glutathione-S-Transferase (anti-GST) was used 
for the first labeling experiences. The results are transmittive due to the general properties 
of all antibodies concerning labeling positions. For final determinations of the Dye-to-Protein 
(D/P) ratio and the alternative Dye Chromeo 546, different anti-Staphylococcus aureus 
Enterotoxins were applied. Labeling experiments with anti-GST and anti-Staphylococcus 
aureus enterotoxin gave the results presented in the following chapters. 
 
4.2. Dyes: Cy3 and Chromeo 546 
Fluorescence dye with optimal properties: Cy3-NHS ester 
<GST> and <SEX> (X: A, B, C, D and H) are labeled with the Cy3-NHS ester. Alternative 
labeling experiments were proceeded with the Chromeo 546-NHS ester. 
 
4.3. Determination of the Appropriate Molar Ratio (MR) 
A series of nine different molar ratios (MRs) is used to label <GST> with Cy3 dye followed by 
a cleaning step using a Sephadex G-25 column. At a MR of one and three, the labeled and 
unlabeled fractions were marginally separatable, so the protein has to be used without 
cleaning. With increasing MR, the length of the zones is increasing and separation is easier. 
Unfortunately, the dilution factor is also increasing with increasing zone length. Optimal Dye-
to-Protein (D/P) ratios are in the region between one and two with the highest fluorescence 
signal that is possible. After measuring the absorbance, best values are expected for ratios 
from ten to 18. After calculating D/P from the absorbance values, optimal D/P results are 
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provided at a MR between ten and twelve followed by a decrease at MRs above 15. The 
fluorescence-to-protein (F/P) ratio is increasing at ratios higher than ten. An MR of twelve is 
chosen for all further labeling experiments, providing most of the criteria (acceptable 
fluorescence intensity and D/P) to be fulfilled. The results are presented in Figure 21.   =              (   )             (       )   =              (       )             (       ) 
 
 
Figure 21. Dye-to-Protein and Fluorescence-to-Protein ratio of the labeled <GST> fractions 
 
 
Figure 22. D/P and F/P ratios of the labeled <SEA> batches 
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A series of three different molar ratios is used to label <SEA> with Cy3 dye followed by a 
cleaning step using the Melon Gel Kit.  After measuring the absorbance, D/P provides 
optimal results at MR = 10 and 12 and is decreasing at MRs above 12. F/P is increasing at 
ratios higher of 10 and 12. An MR of 12 is chosen for all further labeling experiments. The 
results are presented in Figure 22. 
 
4.4. Purification of Labeled Dyes 
Three identically labeled <GST> samples (MR20; this MR is considered to be sufficient in 
[D2]) that are cleaned up using three different methods: a Sephadex-filled glass column, a 
Sephadex-filled plastic column and Millipore Filter Spin Units. The received fractions of each 
clean-up method were picked up for a D/P comparison as presented in Figure 23. All clean-
up methods yield in acceptable D/P and F/P ratios, but the dilution factor is still a problem 
which cannot be solved. Among column-based clean-up types, the plastic column is best due 
to the combination of medium D/P ratios and its practicability. Filter units show similar 
results but were not used again due to their expensiveness. 
 
Figure 23. D/P and F/P ratios of the different column types 
For further comparison of the methods above with advanced cleaning procedures, five 
identically labeled <GST> samples (MR15) that are cleaned up with five different methods. 
Melon Gel Kit and the Nab Spin Plus Kit are used additionally to Filter, Sephadex G15 and 
49 
 
G25 plastic columns. A pure protein reference is used as well. Fractions of all methods were 
picked up for a D/P comparison as presented in Figure 24. The NabPlus Spin Kit uses harsh 
elution conditions of pH 3 and therefore, the linkage between the dye and the protein is 
destroyed during cleaning. This results in very low D/P and F/P values. G25 and the filter 
units show similar reaction as above. G15 seems to be the best choice when using columns, 
due to the higher F/P ratio. Among all clean-up types, the Melon Gel Kit is best due to the 
nearby optimal D/P ratio, a high F/P ratio and its simple and time-consuming handling. 
Melon Gel is used for all further labeling with the Staphylococcal antibodies now. 
     
   Figure 24. D/P and F/P ratios of the different clean-up types 
 
4.5. Determination of Optimal Dye-to-Protein Ratio by Condition Variation 
Enhancements with Cy3 and the Target Antibodies from Staphylococcus aureus Toxins 
A series of five different pH values and two reaction times is proceeded in a labeling 
experiment using <SEA> and <SEB>. Clean-up is done with the Melon Gel Kit. pH values 
lower than eigth require prolonged reaction time because the reaction product is built much 
slower at low pH. At pH values of or above eight, the reaction time can be reduced from 19 
to 1.75 h. As Figure 25 monitors, a pH of 8.3 seems to be the best option for labeling, due to 
the time-saving argument and the near to the physiological pH range. But the F/P is lower 
than the one of pH 8, so there must be partial biological degradation or fluorescence 
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quenching at a pH of 8.3. Due to this fact, a new approach with a shortly prolonged reaction 
time of 4h and pH values nearby the physiological range is started with  <SEA> and <SEB>. 
Using shorter reaction time for lower pH values has a positive effect on the D/P of both 
antibodies (Figure 26). Shortening the reaction time from four to three hours decreases D/P 
and F/P of both antibody types, but the results are still in acceptable ranges. Therefore, a pH 
of 8 and a reaction time of three hours set as standard now (Figure 27). 
 
Figure 25. D/P and F/P ratios of the different reaction conditions for <SEB> 
 
 
Figure 26. D/P and F/P ratios of the different reaction conditions for <SEA> and <SEB> 
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Figure 27. D/P and F/P ratios of the final reaction conditions: pH 8 and 3 h labeling time 
 
Competitive Dye Contest: Cy3 vs. Chromeo 546 
<SEA> and <SEB> are labeled with Cy3 and Chromeo 546 to compare both dyes on similar 
protein targets (Figure 28). At standard conditions, D/Ps for Cy3 are much higher but the 
effective fluorescence intensity of both antibody types is lower. Chromeo 546 has a lower ε, 
but better properties concerning effective fluorescence intensity. This might be due to the 
substituted side group (related to Cy3) and the protection of the surrounding. 
 
Figure 28. D/P and F/P ratios of the dye competition: Cy3 and Chromeo 546 
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Competitive Antibody Contest: Toxin Technology (TT) vs. Acris Antibodies (AA) 
Within this experiment, antibodies from two suppliers (Acris and TT) are tested (Figure 29). 
At standard conditions, all D/P values are all relatively similar and ideal. The F/P values of TT 
antibodies are much lower, but due to the fact that they are all relatively similar, they are 
better to apply on the array all together. So they are used for the microarray experiments. 
 
 
Figure 29. D/P and F/P ratios of the antibody competition: Acris Antibodies and Toxin 
Technology 
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5. Competitive Enterotoxin Microarray 
The aim was to develop a microarray system with low unspecific binding and high signal-to-
background ratios as a detection platform for different enterotoxins with high sensitivity. 
Determination of the binding constants of <SEA> and <SEB> was performed by means of SPR 
(chapter eight) to verify a high specific system. 
A general overview of the applied assay types, using primary and/or secondary antibodies, is 
given in Figure 30. 
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Figure 30. Scheme of the microarray procedure for primary and secondary systems 
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5.1. Primary System: Labeled Primary Antibodies as Detection Elements 
Within this chapter, the development of the primary antibody array system for the EU 
project “BIOTRACER” is described. This first array system is used for the detection of toxins 
in real raw milk samples shown in chapter 5.5.  
 
5.1.1. Antigen Layer Tests on Hydrophobic Patterned Slides and Nitrocellulose Slides 
Chapter 5.1.1 presents the results of the antigen layer tests for hydrophobic patterned and 
nitrocellulose slides. Precise array construction with regard to antigenic surface saturation 
and low surface defect structures is very important as the competitive toxin layer is building 
the binding region for the unbound antibodies within the sample. 
The fluorescence intensity is measured as mean signal intensity for all further analyses. The 
mean signal intensity is the average intensity of the signal pixels. Measurement of the mean 
value decreases the error which is caused by the variation in the amount of immobilized 
decoy deposited on the spot. Herein, the mean signal intensity of Cy3 at 532 nm excitation 
wavelength, F532 Mean, is plotted. All plotted intensities are background-corrected (BG 
corr). 
Hydrophobic Patterned Epoxy Slides 
 
Figure 31. Antigen layer test with SEB on patterned epoxy Slides 
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Table 7. Standard deviation and Signal-to-Background data for Figure 31 
 (F532Mean Background: 442) 
ß(SEB)/(mg/L) 2.5 5 10 15 20 25 30 
Standard 
deviation (F532) 
374 680 917 603 546 1008 743 
Signal-to-
Background ratio 
3.89 5.61 6.70 4.59 3.99 6.54 5.20 
ß(SEB)/(mg/L) 35 40 50 60 70 80 90 
Standard 
deviation (F532) 
794 594 598 2684 1973 677 1362 
Signal-to-
Background ratio 
5.93 6.31 6.30 18.38 13.24 13.77 10.33 
ß(SEB)/(mg/L) 100 120 140 160 180 200  
Standard 
deviation (F532) 
3244 4050 890 2864 6462 11705  
Signal-to-
Background ratio 
13.44 17.89 16.71 17.97 31.30 53.05  
 
A first SEB/Cy3-<SEB> test system for GPTS surfaces was processed on hydrophobic 
patterned slides (Figure 31 and Table 7). Therefore, SEB concentrations from 0-200 mg/L 
were applied to a GPTS-silanized slide. Fluorescence detection of SEB was done by addition 
of 1mg/L Cy3-<SEB> and scanner read-out at 562 nm with an excitation wavelength of 532 
nm. Excitation and emission parameters of the scanner are kept constantly for all further 
array experiments of this thesis. The photomultiplier tube (PMT) voltages of the scanning 
system reach from 10-70, but a mid-range value around 40 is preferred. Herein, a value of 60 
was applied for analysis. The optimal competitive toxin concentration is resided nearby the 
beginning of the fluorescence saturation region of the system. Herein, a SEB concentration 
of 50-60 mg/L seemed to be adequate to form a layer where the fluorescence intensity of 
the Cy3-labeled SEB antibody layer is near the saturation region. On GPTS slides, the signal-
to-noise ratio is optimal and the background is very low at the emission wavelength. These 
two parameters are very important for constructing highly sensitive arrays. Unfortunately, it 
is often very complicated to keep them constant and reproducible. So array construction is 
mainly based on their optimization. 
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Nitrocellulose Slides 
 
Figure 32. Competitive layer test with SEA and SEB on nitrocellulose slides (PMT37) 
Table 8. Standard deviation and Signal-to-Background data for Figure 32 
 (F532Mean Background: 2.35) 
ß(SEA)/(mg/L) 5 10 20 30 40 50 75 100 
Standard 
deviation (F532) 
1.33 0.59 2.36 1.01 0.73 0.59 1.74 1.41 
Signal-to-
Background ratio 
2.91 8.33 8.03 6.48 6.43 9.57 9.26 4.92 
ß(SEB)/(mg/L) 5 10 20 30 40 50 75 100 
Standard 
deviation (F532) 
1.88 0.08 3.27 1.32 2.00 0.07 1.77 1.21 
Signal-to-
Background ratio 
4.02 6.69 8.86 6.49 9.50 12.10 11.98 6.96 
 
First test systems for SEA/Cy3-<SEA> and SEB/Cy3-<SEB> were made on two separate areas 
on one 1-pad nitrocellulose slides (Figure 32 and Table 8). SEA and SEB concentrations from 
0-100 mg/L were incubated on nitrocellulose slides. Fluorescence detection of both types 
was done by addition of 1mg/L of the appropriate Cy3-antibody followed by scanner read-
out.  Toxin concentrations of 40-50 mg/L seemed to be adequate to form a competitive layer 
where the fluorescence intensity is near the saturation region. Both toxin types were 
58 
 
screened on one slide to monitor similar fluorescence intensity regions. This is basically 
necessary for all further array experiments, which should be measurable with similar PMT 
voltage. The signal-to-noise ratio is not optimal because the background of the nitrocellulose 
layer is very high at 562 nm emission wavelength. Therefore, nitrocellulose slides cannot be 
scanned at high PMT voltages which results in lower F532 values, compared to GPTS slides. 
The combination of low PMT voltage, low F532 values and comparably high background 
values at low PMT voltages results in reproduction problems. Furthermore, the 3D-structure 
of this slide type causes high standard deviations due to immobilization failures and irregular 
fluorescence intensity distribution within the spot core. 
Other Slide Types 
 
Figure 33. Competitive layer test with SEB on two different amino slide types 
The third test system contains homemade APTES slides and Erie Super Amino Slides. They 
were incubated with SEB concentrations from 2.5-200 mg/L followed by the incubation of 1 
mg/L Cy3-<SEB> to guarantee comparability of the slide types (Figure 33). Unfortunately, 
both slide types require a further linker system with disuccinimidyl suberate, which is the 
main source of deviations in the reactive layer and extends the array processing time. PMT 
voltage, signal-to-noise ratio and background signal are comparable to GPTS slides for both 
APTES slide types. The result of the homemade APTES slide is not satisfying, the best SEB 
concentration cannot be clearly defined. For Erie Super Amino slides, a SEB concentration 
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between 50 and 60 mg/L seems to be adequate. Due to these negative facts, ATPES slides 
were not used for further array construction. 
 
5.1.2. Labeled Primary Antibody Layer Tests: The Detection Unit on both Slide Types 
Chapter 5.1.2 presents the results of the primary antibody layer tests for hydrophobic 
patterned and nitrocellulose slides. Defining the antibody layer clearly is necessary due to 
fluorescence quenching effects and false-positive or false-negative detection of analytes in 
samples.  For all further experiments, all five toxin types should be measurable on one slide 
with one PMT voltage, so the fluorescence intensities should be relatively similar or at least 
in the same order of magnitude. The ambitious trial is to find appropriate antibody 
concentrations for <SEA> to <SEH> and to establish antibody-toxin layer concentration pairs. 
Hydrophobic Patterned Epoxy Slides 
 
Figure 34. Cy3-antibody layer test for all five toxin types on GPTS slides 
Following the results of the previous chapter, a competitive layer concentration of 50 mg/L 
was chosen for all toxin types. As a detection layer, Cy3-labeled antibodies for SEA-SED and 
SEH were tested from 0.5-6 mg/L (Figure 34 and Table 9). Every antibody-toxin pair was 
tested on a separate slide. Cy3-<SEA> and Cy3-<SEB> provide proper fluorescence intensity 
values at an optimal PMT voltage of 43. 
60 
 
Table 9. Standard deviation and Signal-to-Background data for Figure 34 
 (F532Mean Background: 71.09 (<SEB>), 54.15 (<SEA>)) 
ß(<SEA>)
/(mg/L) 
0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 6 
Standard 
deviation 
(F532) 
390 2097 1379 3405 1742 2794 3623 2267 3361 6128 6541 
Signal-to-
Background 
ratio 
33.6 94.8 155.8 238.6 326 466.5 543.3 583.2 695 885.2 943.8 
ß(<SEB>)
/(mg/L) 
0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 6 
Standard 
deviation 
(F532) 
241 636 1893 2784 2739 1546 3577 3957 4671 2620 2080 
Signal-to-
Background 
ratio 
5.3 20.2 50.9 94.4 139.7 182.6 219 239.3 268.6 291.9 398.5 
 
For Cy3-<SEC> - Cy3-<SEH>, a competitive layer concentration of 50 mg/L is not enough to 
provide similar fluorescence intensity ranges compared to the SEA/Cy3-<SEA> and SEB/Cy3-
<SEB> system. Higher toxin and antibody layer concentrations are applied in the further 
array development to reach the goal of parallel scanning read-out at one PMT voltage. The 
desired antibody concentration for A and B is resided nearby the beginning of the 
fluorescence saturation region of the system. Herein, a concentration of 5 mg/L for A and B 
seemed to be adequate to form a layer where the fluorescence intensity of the Cy3-labeled 
antibody layer is near the saturation region. 
Basically, the A and B-type antibody/toxin system provides increased fluorescence intensity 
values compared to the residual types. This might be caused by increased binding constants 
or more effective labeling with less self-quenching on the antibody or in solution. 
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Figure 35. Cy3-antibody layer test for SEC on GPTS slides 
Table 10. Standard deviation and Signal-to-Background data for Figure 35 
 (F532Mean Background: 55.83) 
ß(<SEC>)
/(mg/L) 
1 2 4 6 8 10 12 14 16 18 20 
Standard 
deviation 
(F532) 
77 187 429 1116 2061 2298 2762 3830 1068 2828 6932 
Signal-to-
Background 
ratio 
2.2 4.8 54 129 197 246 296 369 214 364 489 
For SEC, the toxin layer concentration was increased to 100 mg/L and a Cy3-<SEC> 
concentration from 1-14 mg/L was applied. A SEC concentration of 100 mg/L combined with 
14 mg/L Cy3-<SEC> is providing an adequate pair to fulfill the criteria of the given SEA/SEB 
system PMT voltage, fluorescence intensity range and saturation region (Figure 35 and Table 
10). After analysis of the labeling experiments of <SED> and <SEH>, both antibody types 
monitor decreased D/P and F/P ratios compared to the other three types. The first antibody 
experiments on GPTS arrays are confirming these results additionally due to lower intensity 
values. Therefore, increased toxin layer concentrations of 100-200 (SED) and 100-250 (SEH) 
were incubated. Furthermore, increased antibody concentrations from 1-30 (<SED>) and 1-
20 (<SEH>) were applied (Figure 36 and Table 11). Finally, concentration pairs of 200 mg/L 
SED/25 mg/L Cy3-<SED> and 250 mg/L SHE/20 mg/L Cy3-<SEH> were chosen. Unfortunately, 
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within this concentration ranges the fluorescence intensity values of SEA-SEC could not be 
reached at PMT43. Furthermore, labeling efficiency could not be improved and the toxin and 
antibody concentrations could not be increased any more due to the extremely high prices. 
 
Figure 36. Cy3-antibody layer test for SED and SEH on GPTS slides 
Table 11. Standard deviation and Signal-to-Background data for Figure 36 
 (F532Mean Background: 37.71 (<SED>), 17.67 (<SEH>); ß(SED)=200 mg/L, ß(SEH)=250 mg/L) 
ß(<SED>)
/(mg/L) 
2.5 5 10 12.5 15 17.5 20 22.5 25 27.5 30 
Standard 
deviation 
(F532) 
66 111 293 374 484 232 350 591 393 435 557 
Signal-to-
Background 
ratio 
6.2 11.2 23.8 30.8 33.8 40.1 47.7 53.7 55.7 60.4 80.4 
ß(<SEH>)
/(mg/L) 
1 2 4 6 8 10 12 14 16 18 20 
Standard 
deviation 
(F532) 
6.95 16.6 15.97 11.43 28.34 15.88 23.54 28.95 19.94 102.2 49.35 
Signal-to-
Background 
ratio 
0.77 1.15 1.97 3.95 5.27 6.80 9.54 12.18 13.66 10.37 17.84 
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For SEC, the toxin layer concentration was increased to 100 mg/L and a Cy3-<SEC> 
concentration from 1-14 mg/L was applied. A SEC concentration of 100 mg/L combined with 
14 mg/L Cy3-<SEC> is providing an adequate pair to fulfill the criteria of the given SEA/SEB 
system PMT voltage, fluorescence intensity range and saturation region (Figure 35 and Table 
10). After analysis of the labeling experiments of <SED> and <SEH>, both antibody types 
monitor decreased D/P and F/P ratios compared to the other three types. The first antibody 
experiments on GPTS arrays are confirming these results additionally due to lower intensity 
values. Therefore, increased toxin layer concentrations of 100-200 (SED) and 100-250 (SEH) 
were incubated. Furthermore, increased antibody concentrations from 1-30 (<SED>) and 1-
20 (<SEH>) were applied (Figure 36 and Table 11). Finally, concentration pairs of 200 mg/L 
SED/25 mg/L Cy3-<SED> and 250 mg/L SHE/20 mg/L Cy3-<SEH> were chosen. Unfortunately, 
within this concentration ranges the fluorescence intensity values of SEA-SEC could not be 
reached at PMT43. Furthermore, labeling efficiency could not be improved and the toxin and 
antibody concentrations could not be increased any more due to the extremely high prices. 
 
Nitrocellulose Slides 
 
Figure 37. Cy3-antibody layer test for SEA and SEB on two 16-pad nitrocellulose slides 
Following the results of the previous chapter, a competitive layer concentration of 50 mg/L 
was chosen for both toxin types. As a detection layer, Cy3-labeled antibodies for SEA and 
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SEB from 0.1-2 mg/L (Figure 37 and Table 12). Every antibody-toxin pair was tested on a 
separate slide. Cy3-<SEA> and Cy3-<SEB> provide proper fluorescence intensity values at an 
optimal PMT voltage of 30 and 28. Herein, a concentration of 1.25 mg/L for A and B seemed 
to be adequate to form a layer where the fluorescence intensity of the Cy3-labeled antibody 
layer is near the saturation region.  
Table 12. Standard deviation and Signal-to-Background data for Figure 37 
ß(<SEA>)
/(mg/L) 
0.075 0.1 0.2 0.4 0.6 0.8 1.0 1.25 1.5 1.75 2 
Standard 
deviation 
(F532) 
867 592 420 536 2964 942 2910 2236 1164 6076 1519 
Signal-to-
Background 
ratio 
1.06 1.23 1.12 1.05 1.29 1.59 1.87 2.18 1.68 1.56 2.17 
ß(<SEB>)
/(mg/L) 
0.075 0.1 0.2 0.4 0.6 0.8 1.0 1.25 1.5 1.75 2 
Standard 
deviation 
(F532) 
174 188 242 331 2.07 333 2132 2750 2635 4340 462 
Signal-to-
Background 
ratio 
1.21 1.15 1.21 1.34 1.58 1.49 1.21 2.68 2.12 2.91 2.59 
 
5.1.3. Competitive Assay Development on Nitrocellulose Slides and Hydrophobic Patterned 
Slides 
Competitive tests on all microarray types are made to determine the region, where the 
fluorescence intensity decreases linearly with increasing concentration. This is called the 
“Linear Range” or the “Linear Concentration Range”. Within this linear region, the toxin 
content of samples with unknown toxin concentration can be determined via linear 
regression. This principle works similarly for all competitive measurements on SPR chips, 
where the Linear Range has to be defined, too. 
Competitive Toxin Standards in PBS buffer: the Comparison 
Nitrocellulose Slides 
Figure 38. Scan of a competitive 16
On this 16-pad nitrocellulose array picture, the small 16
visible (Figure 38). Often, the value of 0 mg/L toxin is not measurable due to 
fluorescence intensity compared to the other pads.
Figure 39. Competitive toxin assay f
 
-pad Fast Slide at PMT40 
-pin constructed toxin layer spots are 
the high 
 
 
 
or SEA and SEB on one 16-pad nitrocellulose slide 
A concentration of 50 mg/L competitive SEA or 
slides followed by an antibody layer of 1.25 mg/L. Toxin sample concentrations from 0
mg/L SEA or SEB in PBS buffer were used. 
competitive toxin between 0 and 0.2 
(Figure 39). This region is defined generously for real sample trials.
from 0-0.1 mg/L (0-100 ng/mL) can be defined with R
monitored between 0.05 and 0.15 mg/L (50
SEB experiments show excellent accordance of fluorescence intensities at 562 nm emission 
wavelength. Unfortunately, the signal
too far away from the BIOTRACER requirements
this, all further experiments are applied
Hydrophobic Patterned Epoxy Slides
A concentration of 50 mg/L competitive SEA or SEB was applied on GPTS slides followed by 
an antibody layer of 5 mg/L. These are the standard concentrations for all further SEA and 
SEB-based GPTS arrays. 
Figure 40. Graph and scanning picture of the first competitive trial with SEA and SEB on 
hydrophobic patterned epoxy slides 
SEB was applied on 16-pad nitrocellulose 
Both arrangements monitor a decrease for 
mg/L, which corresponds to a region of 0-200 ng/mL
 For SEA, a linear region 
2=0.932. For SEB, this region is 
-150 ng/mL) with R2=0.994. Competitive SEA and 
-to-noise ratios are low again and the linear range is 
 of 0.1-10 ng toxin/mL sample. Because of 
 on GPTS slides only. 
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As a first trial, SEA and SEB samples in PBS buffer were applied in the range of 0-5 mg/L to 
get an overview of the general fluorescence intensity trend of the epoxy array system 
(Figure 40). Application of 5 mg/L toxin is the upper limit, due to a “labeled antibody”- layer 
of 5 mg/L. Fortunately, the fluorescence intensity is in a relatively high range at medium 
PMT voltage of 41. This is a very desirably appearance and accomplishes excellent starting 
conditions for the competitive array development. Both curves, for SEA and SEB, are 
decreasing until 2 mg/L. This indicates an accurate reaction process of antibody and toxin. 
Within the region of 0-2 mg/L competitive SEA or SEB, the slope is decreasing by trend. This 
enables the standardization as calibration region and has to be proven by further 
experiments. 
 
Figure 41. Results of the new concentration range for competitive SEA and SEB (0-2 mg/L) 
As already determined on the former experiment, the concentration range of 0-2 mg/L of 
competitive toxin decreases the fluorescence intensity at medium PMT voltages (Figure 41) 
and provides good possibilities for being used as calibration region. Due to the high risk of 
being intoxicated at low toxin concentrations of 0.1 mg per ingested sample, the range has to 
be further decreased. A new range of 0-0.25 mg/L was chosen for SEA and SEB. 
A concentration of 100 mg/L competitive SEC and 14 mg/L Cy3-<SEC> was used for GPTS 
slides. SEC samples in PBS were applied in the range of 0-14 mg/L to get an overview of the 
general fluorescence intensity trend of the epoxy system (Figure 42). Application of 14 mg/L 
toxin is the upper limit, due to a labeled antibody input of 14 mg/L. Unfortunately, the 
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fluorescence intensity is only in a mid range at medium PMT voltage of 41. The curve is 
decreasing over the progression of 0-8 mg/L and ends in a saturation region. Within the 
region of 0-1 mg/L competitive SEC, the slope is decreasing linearly by trend. This potential 
dynamic calibration region has to be proven by further experiment. 
 
 
Figure 42. Graph of the first competitive trial with SEC on a hydrophobic patterned slide 
Finally, the toxins SED and SEH are added to the competitive system and all five toxin types 
are tested at the same PMT voltage to generate on overview of calibration ranges and 
fluorescence intensity ranges of the different types of toxins (Figure 43). A concentration of 
200 mg/L competitive SED and 25 mg/L Cy3-<SED> was used for GPTS slides. 250 mg/L and 
20 mg/L were used for toxin type SEH. 
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Figure 43. Comparison of all five toxin types on three slides with one PMT voltage (PMT52) 
All five toxin types were tested at a PMT voltage of 52. This corresponds to the need of a 
voltage in the mid-region of the bandwidth. For SEA and SEB, the competitive range of 0-
0.25 mg/L toxin was tested. The SEA curve is decreasing linearly for concentrations 
beginning at 50 ng/mL (0.05 mg/L), up to 250 ng/mL (0.25 mg/L), with R2=0.988. For SEB, the 
curve is linearly decreasing from 50-225 ng/mL with R2=0.993. The slope of the SEA curve is 
decreasing significantly whereas the SEB curve decreases slightly. It is not possible to verify 
the calibration regions of interest from 0.1-10 ng/mL with this array type. In general, a linear 
region comprises minimum one decade of concentration. In addition, a minimum signal 
decrease of 10% has to be reached within the defined range. Only the second criteria can be 
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fulfilled for the SEA and SEB curves. Finally, this array type can be used for highly 
contaminated food samples, but do not fulfill the BIOTRACER criteria.  
For SEC, a range of 0.1-1 mg/L seems to be linear with slight decrease, but the interesting 
region of 0-0.1 mg/L is also not defined clearly. Fortunately, the curve of the region 0.1-1 
mg/L is corresponding to the linear range demands. The range of 0-0.1 mg/L could not be 
monitored in all experiments of this array type due to extremely differences in the 
characteristics of the curve. Linearity is expected within this range, but could not be 
monitored precisely. Unfortunately, the fluorescence intensity is in the lower region at 
PMT52. SED and SEH were applied in the range of 0-17.5 mg/L (SED) and 0-16 mg/L (SEH) to 
get an overview of the characteristics of the GPTS system. Unfortunately, the fluorescence 
intensity for SEH is only in a mid range at medium PMT voltage of 52 whereas the intensity 
for SED is optimal. The SED curve is decreasing over the progression of 0-17.5 mg/L, the SEH 
curve starts to decrease at 6 mg/L. Within the region of 0-17.5 mg/L competitive SED, two 
potential calibration regions can be monitored. The first region reaches from 0-5 mg/L, with 
a R2 of 0.99. The second is monitored from 7-16 mg/L with a R2 of 0.99. Only the first range is 
attractive for measurements within the BIOTRACER requirements. The concrete 
characteristics were shown in further experiments with PBS and milk. For SEH, a region with 
potential linear decrease was setted from 6-14 mg/L with a R2 of 0.938. This low R2 value 
indicates the uncertainty of this region and points the need of a lower range for calibration. 
The competition: milk and PBS standards on Patterned Epoxy Slides 
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Figure 44. Competitive experiments for SEA-SED/SEH in PBS buffer and UHT milk 1.5% fat 
The toxin concentration ranges of 0-0.04 mg/L (SEA-SEC) and 0-0.2 mg/L (SED and SEH) are 
mixed in PBS buffer and undiluted UHT milk (1.5% fat content) for a competition test (Figure 
44). The milk charges can be considered as artificially contaminated milk samples. The toxins 
are pre-incubated with the UHT milk to guarantee their natural adaption into the milk 
matrix. Antibody additions are made similarly for all solvent types, PBS buffer and milk. In 
general, the fluorescence intensities for toxins bound to labeled antibodies in milk are lower 
than those for PBS buffer. All fluorescence intensities can be detected at a PMT voltage in 
the mid-range and belong to the same dimension. For SEC, the low R2 values in milk and PBS 
indicate the beginning of the linear range between 20-40 ng/mL. For SEA and SEB, the high 
R2 values near 1 suggest linearity over the whole range, but the characteristics of the milk 
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experiments are monitoring other tendencies. Like for SEC, the beginning of the linear range 
seems to be between 20-40 ng/mL or at concentrations above 40 ng/mL. For SED and SEH, 
the linear ranges are starting between 100-200 ng/mL toxin content or above 200ng/mL.This 
is rather indicated by the low R2 for SED in PBS and milk. This estimation method cannot be 
applied for SEH, as R2 is too near to 1.  
The criteria of detecting 0.1-10 ng/mL sample cannot be fulfilled at this stage of 
development. Furthermore, the criterium of covering minimum one concentration decade is 
not proceeded. Undiluted milk samples induce no detection problems concerning 
background fluorescence or smearing of the array surface. Pipetting of 1 mL milk spots on 
the array is not as easy as with PBS, due to the lipophilic character of the sample. Detection 
of toxins in large sample volumes requires large amounts of labeled antibody and was not 
applicable within this project budget. Another problem of the primary system is the 
existence of five types of labeled antibodies with five different dye-to-protein ratios and 
therefore different basic fluorescence intensities of the labeled solutions. Furthermore, 
discrepancies in fluorescence intensities on the array are expected due to the disparing 
association constants (KA) of the antibodies and their differing D/P ratio. This requires 
fluorescence normalization for all antibody types on the array and makes array analysis very 
complex. Generally, fluorescence intensities of the five toxin arrays differ too much as well 
as the standard deviations are too high (around 15-30 %). Positively, the signal-to-noise 
ratios are high and the background intensities are low. 
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5.2. Alternative System on Patterned Slides: Secondary Antibodies as Detection Elements 
Within this chapter, the development of an alternative array system is described. Toxin layer 
and primary antibody layer concentrations are kept constant. Only a new layer with a 
secondary, Cy3-labeled antibody is added to avoid the problems caused by five separate 
labeled <SEX> with differing D/P and F/P. All primary antibodies are used unlabeled from 
now on. 
 
5.2.1. The Detection Unit: Labeled Secondary Antibody Layer Tests 
 
Figure 45. Concentration tests for secondary Cy3-labeled goat-<SEX>  
The need of fluorescence normalization due to five different efficient antibodies was 
eliminated via secondary, Cy3-labeled polyclonal antibody (Figure 45 and Table 13). The 
basic concentration pairs (toxin SEX and <SEX>) are kept constant for all five toxins types. For 
a comparison, the SEB pair was alternatively detected with monoclonal primary <SEB> and 
secondary Cy3-antibody. All polyclonal variants exhibit adequate fluorescence intensities at 
a moderate PMT voltage. Except the monoclonal variant offers low fluorescence and 
requires high concentrations of secondary antibody for acceptable intensity. 50 mg/L 
polyclonal secondary antibody is considered to be sufficient to obtain moderate intensity 
values at PMT38 for this new array type. 
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5.2.2. Competitive Assay Development: Linear Detection Ranges for Enterotoxins 
As next step, the new secondary system was tested within a competitive assay (Figure 46). 0-
35 ng/mL toxin samples in PBS were prepared for SEA, SEB and SED. 50 mg/L secondary 
antibody was applied as detection element with moderate PMT voltage. This resulted in 
excellent fluorescence intensities and close intensity ranges for all three tested toxin types. 
Linear regions can be defined as 7.5-22.5 ng/mL for SEA, 2.5-10 ng/mL for SEB and 15-35 
ng/mL for SED. Low R2 values for SEA and SEB indicate the high uncertainties, only the SEH 
curve possesses a R2 near 1. Except the SEB curve was within the requirement of detecting 
0.1-10 ng/mL toxin in the sample. The criterium of covering minimum one concentration 
decade is not achieved for any array.  
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Figure 46.                                                                                                                             
Competitive assay for the secondary system (50 mg/L Cy3-labeled secondary antibody) 
A defined array improvement in fluorescence intensity and linear regions is monitored by 
the use of polyclonal secondary Cy3-labeled antibody. Unfortunately, the systems for 
individual toxins differ again, so a complete new array system is constructed with the use of 
secondary Cy3-labeled antibody. 
5.2.3. Advanced Secondary Systems 
Antigen Layer Tests on Epoxy Slides   
 
Figure 47. Antigen layer test with the new secondary system on epoxy slides 
First <SEX> (A-C) antibody concentrations of 1 and 5 mg/L were applied to build an overview 
test system of the GPTS surface (Figure 47 and Table 13). The slides were coated with a 
concentration of 10-250 mg/L toxin. This new system is based on polyclonal primary 
unlabeled antibodies and a secondary Cy3-labeled antibody (5mg/L) and includes a 
completely new development of all layers. Herein, a concentration of 50-75 mg/L seems to 
be adequate for SEA and SEB to form a layer where fluorescence intensity is near the 
saturation region at a moderate PMT value of 33. The signal-to-noise ratio is optimal on 
GPTS slides, the background is very low at 562 nm emission wavelength. By trend, a primary 
antibody concentration of 5 mg/L is more adviced than 1 mg/L with regard to fluorescence 
intensities. 
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Table 13. Signal-to-Background data for Figure 47 
ß(SEA)/(mg/L) 
(<SEA> 1 mg/L) 
10 20 30 40 50 75 100 150 200 250 
Signal-to-
Background 
ratio 
92.7 121.1 124.7 132.7 140.2 113.7 79.9 27.2 24.7 24.1 
ß(SEA)/(mg/L) 
(<SEA> 5 mg/L) 
10 20 30 40 50 75 100 150 200 250 
Signal-to-
Background 
ratio 
29.2 62.1 150.6 277 258.3 398.5 371.9 308.1 230.8 151.9 
ß(SEB)/(mg/L) 
(<SEB> 1mg/L) 
10 20 30 40 50 75 100 150 200 250 
Signal-to-
Background 
ratio 
328.6 321.2 308.6 440.5 380.5 352.9 150.7 94.7 46.4 55.6 
ß(SEB)/(mg/L) 
(<SEB> 5 mg/L) 
10 20 30 40 50 75 100 150 200 250 
Signal-to-
Background 
ratio 
28.7 76.6 148.3 326.7 583.6 611.3 618.9 678.8 719.2 735.7 
 
 
Figure 48. Antigen layer test with a comparable primary system on epoxy slides 
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Table 14. Signal-to-Background data for Figure 48 
ß(SEA)/(mg/L) 
(<SEA> 1 mg/L) 
10 20 30 40 50 75 100 150 200 250 
Signal-to-
Background 
ratio 
1.97 2.24 3.19 3.84 4.30 4.56 4.62 4.65 6.54 6.64 
ß(SEA)/(mg/L) 
(<SEA> 5 mg/L) 
10 20 30 40 50 75 100 150 200 250 
Signal-to-
Background 
ratio 
5.02 5.64 5.94 7.40 8.58 12.22 14.95 15.04 16.74 15.43 
ß(SEB)/(mg/L) 
(<SEB> 1mg/L) 
10 20 30 40 50 75 100 150 200 250 
Signal-to-
Background 
ratio 
5.31 5.87 7.5 10.27 12.35 14.02 13.71 15.81 15.97 14.47 
ß(SEB)/(mg/L) 
(<SEB> 5 mg/L) 
10 20 30 40 50 75 100 150 200 250 
Signal-to-
Background 
ratio 
43.63 45.03 72.71 90.10 112.2 116.2 112.1 123 135.9 151.7 
 
Cy3-<SEA> and Cy3-<SEB> concentrations of 1 and 5 mg/L were applied to build an 
alternative primary overview test system of the GPTS surface (Figure 48 and Table 14). This 
comparison system is based on polyclonal primary Cy3-labeled antibodies and includes a 
completely new development of all layers. Herein, a concentration of 75 mg/L seems to be 
adequate for SEA and SEB to form a layer where fluorescence intensity is near the saturation 
region. For SEC, 100 mg/L are suggested. The signal-to-noise ratio is optimal on GPTS slides 
and the background is very low at 562 nm emission wavelength. Again, a primary antibody 
concentration of 5 mg/L is more adviced than 1 mg/L with regard to fluorescence intensities. 
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Primary Antibody Layer Tests 
The ambitious goal is to find appropriate antibody concentrations for <SEA>-<SEC>. As a 
third layer, Cy3-labeled secondary antibody was used with a concentration of 5 mg/L. 
 
Figure 49. Primary antibody layer tests for <SEA>-<SEC> (Cy3-sec. Ab: 5 mg/L) on epoxy 
slides with the secondary system (SEC) 
Table 15. Signal-to-Background data for Figure 49 
ß(<SEA>)/(mg/L) 0.5 1 2 4 6 7.5 9 10 12.5 15 
Signal-to-
Background 
ratio 
29.6 65.1 103.5 109.4 121 142.1 168.1 157.3 169.4 212 
ß(<SEB>)/(mg/L) 0.5 1 2 4 6 7.5 9 10 12.5 15 
Signal-to-
Background 
ratio 
66.8 128.7 212.5 283.1 283.9 287.2 289.1 256.4 239.2 244.5 
ß(<SEC>)/(mg/L) 0.5 1 2 4 6 7.5 9 10 12.5 15 
Signal-to-
Background 
ratio 
4.2 7 8.9 18.1 30.8 49.8 72.2 83.7 99 102.3 
 
Within the new secondary antibody system, 2 mg/L <SEA>-<SEC> provide proper 
fluorescence intensity and signal-to-background values at a PMT value of 39 for the given 
conditions (Figure 49 and Table 15). 
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Figure 50. Primary antibody layer tests for Cy3-<SEA> and Cy3-<SEB> on epoxy slides 
Table 16. Signal-to-Background data for Figure 50 
ß(<SEA>)/(mg/L) 0.5 1 2 4 6 7.5 9 10 12.5 15 
Signal-to-
Background 
ratio 
1.16 1.22 1.25 1.24 1.27 1.27 1.37 1.50 1.71 1.95 
ß(<SEB>)/(mg/L) 0.5 1 2 4 6 7.5 9 10 12.5 15 
Signal-to-
Background 
ratio 
1.97 8.02 21.91 34.42 49.77 67.01 81.48 76.57 93.53 76.95 
 
4 mg/L Cy3-<SEA> and Cy3-<SEB> provide proper fluorescence intensity values at an optimal 
PMT voltage of 45 (Figure 50 and Table 16). Furthermore, the concentration is below the 
satisfaction region and therefore with the optimal range.  Compared to the new secondary 
system, the fluorescence intensity is lower and an increased antibody concentration is 
needed. This is unprofitable with regard to linear ranges for which the antibody 
concentration should be as low as possible to generate an acceptable competitive range for 
toxins. This means the complete range of antibody concentration in its toxin-bound variant, 
starting from 0 mg/L to the used concentration, e.g. 4 mg/L, should create the linear region. 
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Competitive Array Test for SEA 
 
 
Figure 51. Results of the competitive array test with the new secondary system for SEA 
Finally, the new secondary system was tested within a competitive assay (Figure 51). 5 mg/L 
secondary antibody was applied as detection element and a moderate PMT voltage was 
applied. This resulted in moderate fluorescence intensities. The fluorescence intensities have 
large standard deviations and therefore they are not acceptable. Furthermore, a linear 
region can be monitored from 40-90ng/mL with a low R2 of 0.95. For this new system, the 
criteria of detecting 0.1-10 ng/mL sample cannot be fulfilled at this stage of development 
either. Concentrations below 40 ng/mL cannot be calculated by linear regression. 
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Furthermore, the criterium of covering minimum one concentration decade is not 
proceeded.  
Table 17. Overview of LODs and linear ranges for all tested competitive systems 
System Toxin type LOD (estimated) Linear range / (ng/mL) 
Primary (PBS) SEA 5 10-40 
 SEB 5 10-40 
 SEC 8 10-40 
 SED 25 50-200 
 SEH 40 50-200 
Primary (Milk) SEA 5 10-40 
 SEB 7 10-40 
 SEC 5 10-40 
 SED 25 50-200 
 SEH 40 50-200 
Secondary 
(1st configuration) 
SEA 5 5-25 
 SEB 1 1.25-10 
 SED 14.5 15-35 
Secondary 
(Advanced) 
SEA 36 40-90 
 
An overview of LODs and linear ranges of all tested systems is presented in Table 17. With 
Biotracer requirements of detecting 0.1-10 ng toxin/mL sample, only the 1st secondary 
configuration matches the needs. All other systems are not sensitive enough and provide a 
list of changellenges that are still to solve. 
 
5.3. Cross-reaction Tests                                      
5.3.1. Primary Detection System 
Polyclonal Primary Antibody Systems: Cross-Reaction Array with Fluorescence Normalization 
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SEA, SEB, SEC, SED, SEH and their primary fluorescence-labeled antibodies were spotted on 
one array for direct competition. Every toxin and antibody type was combined. Detection 
occurs via Cy3-label on the primary antibody. Fluorescence normalization is necessary due to 
the application of 5 Cy3-labeled primary antibodies with differing D/, F/P and fluorescence 
intensity within the same concentration. Normalization is done via separate normalization 
array and equations.  
 
 
Figure 52. Results of the cross-reaction test of the primary system 
The cross-reaction assay was carried out with the following parameters: SEA-SEH: each 50 
mg/L, <SEA>-<SEH>: each 25 mg/L with a blocking time of 0.75 h. All 25 possible 
combinations of antibody and toxin on the surface were applied. The results are presented 
in Figure 52. The matching combination pair is calculated to 100% percent, all others are 
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adjusted. Only <SEA> is highly specific for SEA, which is monitored by low percentage values 
of the other combinations. <SEB> reacts nearly similar with SEA and SEB. <SEC>-<SEH> are 
highly cross-reacting with other types. As presented in 5.3.2, high specifity cannot be 
monitored for all matching combinations. Therefore it can be assumed that problems caused 
by five labeling procedures and their clean-up yield in this high cross-reactivity structure. The 
primary system shows less specifity of different types and provides non-optimal conditions 
for array construction. 
 
5.3.2. Secondary Detection System 
Monoclonal Antibodies in Secondary Systems: Cross-Reaction Performance 
SEA, SEB, SEC, SED, SEH and monoclonal <SEB> were spotted on one array for direct 
competition. Detection occurs via Cy3-labeled secondary goat-<mouse>. The assay was 
carried out with the following parameters: SEA-SEH: 50/50/100/250/200 mg/L, <SEB>: each 
5 mg/L and secondary Cy3-antibody: 100 mg/L with a blocking time of 1h. The results are 
presented in Figure 53. 
 
Figure 53. Results of the cross-reaction test of the monoclonal system 
This monoclonal system shows specifity for SEB, but also for SEH. This system does not show 
specifity for SEB in samples that contain SEB and SEH and therefore provides non-optimal 
conditions for array construction. 
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Advanced Secondary System 
SEA, SEB, SEC and their primary antibodies were spotted in all combinations on one array for 
direct competition. Detection occurs via Cy3-labeled secondary goat-<rabbit>. The assay was 
carried out using the following parameters: SEA-SEC: each 75 mg/L, <SEA>-<SEC>: each 4 
mg/L and secondary Cy3-antibody: 5 mg/L with a blocking time of 1h.  
 
 
Figure 54. Results of the cross-reaction test of the new system 
The results are presented in Figure 54. The matching combination pair is calculated to 100% 
percent, all others are adjusted. All antibodies are highly specific for their toxin, which is 
monitored by low percentage values of the other combinations. This new secondary type of 
assay with low cross-reaction reactivity of different types of toxins provides best conditions 
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for array construction. The low selectivity and high cross-reactivity of the primary system is 
not induced from the antibody and the toxin itself. Quenching problems of the Cy3 dye or 
strerical hindrance of antiboidy and toxin due to the dye presence within the primary 
antibody incubation step can be the reason for the results in the primary incubation test.  
 
5.4. Buffer Tests 
5.4.1. Blocking Buffer 
After the spotting of enterotoxin(s) on the array surface, there are free binding sites left. To 
cover the free binding areas and to prevent unspecific binding, the slides are immersed in 
blocking solution. Two different blocking types are used, protein and protein-free blockers, 
whereas Nexterion Blocker and Pierce Blocking Buffer belong to the second category. Casein 
Blocker and bovine serum albumin (BSA)-containing solutions are protein buffers. Protein-
free blocking buffers were also applied due to the risk of high background fluorescence 
when using protein blocking buffers. Different blocking buffer types were spotted on one 
array for direct competition. Nexterion Blocking Buffer, Pierce Blocking Buffer, 5% BSA in 1x 
PBS pH 7.4 and 5% BSA in Pierce Blocking Buffer were compared. The assay was carried out 
on an SEB-Array (SEB: 50 mg/L, <SEB>: 2 mg/L and secondary Cy3-antibody: 5 mg/L) with a 
blocking time of 1h.  
 
Figure 55. Results of the Blocking Buffer Test 
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Figure 56: Effect of different blocking buffers on the fluorescence intensity of microarray 
spots: Pierce Buffer, 5% BSA in PBS, 5% BSA in Pierce Buffer and Nexterion Blocking Buffer 
(from left to right) 
 
The results are presented in Figure 55 and 56. Pierce Buffer without BSA effects higher 
fluorescence intensity than its variant with BSA content and the classic BSA blocking buffer 
itself. This leads to the assumption that Pierce Buffer is blocking only fragmentary and 
unspecific binding of labeled antibodies is happening. Nexterion Buffer reacts in similar ways 
like classic BSA blocking buffer. BSA blocking buffer buffer and Nexterion Buffer are the best 
choices. Due to its relatively high price, Nexterion Buffer is the second choice and the 
homemade 5% BSA buffer is used now. 
 
5.4.2. Spotting Buffer 
Different types of spotting buffer were tested to prevent high background fluorescence and 
low immobilization rate of the toxins due to buffer evaporation effects (Figure 58). 
Furthermore, three spotting buffer types were prepared on one array for direct competition. 
1 x PBS pH 7.4, 1x PBST pH 7.4 (0.5% Tween20) and Nexterion Spotting LE were compared. 
The assay was carried out on an SEB-Array (SEB: 50 mg/L, <SEB>: 2 mg/L and secondary Cy3-
antibody: 5 mg/L) with a blocking time of 1h. The results are presented in Figure 57 and 58. 
Due to the relative low fluorescence intensities of Nexterion Spotting LE and 1 x PBST pH 7.4 
buffer, 1 x PBS pH 7.4 buffer was chosen as spotting buffer. Furthermore, 1 x PBS pH 7.4 
effects relatively uniform distribution of fluorescence intensity within the spot and good 
inter-spot equivalence. 
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Figure 57. Results of the Spotting Buffer Test 
 
Figure 58. Effect of different spotting buffers on the fluorescence intensity of microarray 
spots: 1 x PBS pH 7.4, 1 x PBST pH 7.4 and Nexterion Spotting Buffer (from left to right) 
 
5.5. Primary System: Raw Milk as Sample Application 
In this chapter, raw milk samples from Switzerland are tested with the primary system due 
to the requirements of the BIOTRACER project. 
 
Calibration Measurements for the Detection of Toxins in Raw Milk Samples 
The calibration curves for SEA, SEB, SEC and SEA/SEB/SEC in PBS and uncontaminated raw 
milk from Switzerland are presented in Figure 59. 
The results of tested raw milk samples are presented in Figure 60 and 61. 
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Figure 59. Calibration curves for the detection of toxins in raw milk sample 
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Figure 60.                                                                                                                             
Results for all tested raw milk samples and toxin types (SEA, SEB, SEC or SEA/SEB/SEC) 
 
Figure 61. Calculated results of the raw milk array experiment 
 
Detection of Toxins in Raw Milk Samples from Switzerland (5% raw fat content) 
The calibration curve for the overall toxin concentration of SEA-SEC is calculated without any 
problems. All other calibration curves have parabola-like curves with 2 x-values per y-value. 
A well-defined correlation of concentration and sample values is not possible therefore. A 
possible explication might be the self-quenching of bound labeled primary antibody in the 
milk matrix. Concentrations below 15 ng/mL (SEA) and 10 ng/mL (SEB) monitor this limit. 
The only guideline for contamination that is given, are the microbial determinations of the 
samples which allow a systematically definition. Only Tankmilk 12 exhibits a low 
concentration of S. aureus Enterotoxin-expressing strains, all other samples do not contain 
toxin-expressing strains. So, only Milk 12 is able to build enterotoxins within the given terms. 
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The results of the raw milk experiment are presented in Figure 60 and 61. All values for the 
1:10 dilutions have to be measured again with 1:10 milk in PBS standard curves, due to the 
different consistency of pure milk and the 1:10 mixture. As only Tankmilk 12 contains the 
correct strains for toxin production, only samples 1 and 6 could be contaminated naturally. 
All other samples which are prepared with Tankmilk 12 are contaminated artificially in 
excess. Tankmilk 1 is completely free of Staphylococcus strains and therefore used as blank 
and spiking milk. So, samples 2, 8 and 9 are artificially contaminated and contain SEA or SEB. 
For the gross sum of SEA/SEB/SEC, all samples were analyzed correctly with regard to the 
status  “contaminated/uncontaminated”, only the value itself is often not correct. Sample 1 
and 3-6 are analyzed correctly as negative due to the prediction of the microbial pre-
examination. Sample 2 and 8-10 are analyzed correctly as contaminated samples. After 
precalculations due to spiking volumes and concentrations (SEA and SEB, samples 2 and 8-
10), Sample 2 and 10 should contain around 5.33 ng/mL, due to the compression rate after 
centrifugation. Sample 8 should contain 4 ng/mL, because it is not treated after spiking. 
Sample 9 should possess a value of 46.2 ng/mL after centrifugation. The false results of 
sample 2, 8 and 10 might be caused by the linear range which is starting at higher 
concentrations. The concentration in sample 9 is 16% above the spiked concentration. This 
result is within a conventional frame of standard deviation. For SEA, 6 from 9 samples were 
analyzed correctly with regard to the status “contaminated/uncontaminated”. Sample 1-6 
are analyzed correctly as negative due to the prediction of the microbial pre-examination. 
Sample 10 was not recognized as an SEA-containing sample (false-negative) whereas 
samples 8 and 9 were analyzed misleadingly as such types (false-positive). Unfortunately, 
sample 10 could not be calculated. For SEB, 4 from 9 samples were analyzed correctly with 
regard to the status “contaminated/uncontaminated”. Samples 1, 3, 8 and 9 were analyzed 
correctly. Unfortunately, sample 8 and 9 cannot be calculated. Sample 2 was not recognized 
as SEB-containing analysis. Samples 4-6 and 10 should not contain any SEB, they are 
recognized as false-positives! For SEC, 6 from 9 samples were analyzed correctly with regard 
to the status “contaminated /uncontaminated”. Samples 1-6 are analyzed correctly, samples 
8-10 are false-positives.  
False-positive and false-negative results are induced by the cross-reaction of antibodies and 
toxins, due to the structural and genetic similarity.  
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The experiment could not be repeated a second time due to the time and sample limit 
during the stay at the Veterinary University of Vienna. 
 
5.6. Comparison with the miniVIDAS system for Sample Applications 
In this chapter, the miniVIDAS system is tested with SEA-spiked raw milk cheese samples and 
SET2. The method uses an enzyme-linked fluorescent assay with polyclonal anti-enterotoxin 
antibodies. The Vidas SET2 is a rapid and fully automated kit detecting, without 
differentiation, the SEA to SEE, using a cone coated with antibodies specific for SEA, SEB, 
SECs, SED and SEE. An immune complex is formed between (i) the coated antibodies, (ii) the 
toxins in the concentrated extract and (iii) the anti-SE antibodies conjugated with alkaline 
phosphatase. All reagents are included in the wells of the strip used. Briefly, 0.5 mL of the 
concentrated protein extract or 0.5 mL of the controls (positive or negative) are distributed 
in the strip and incubated in the automate miniVIDAS. Two fluorescence measurements 
(sample, blank) are performed for each test by the automate. The ratio (relative 
fluorescence value) between these two measurements is interpreted to declare or not a 
sample as positive. The miniVIDAS method has a sensitivity of at least 0.5 ng/g food. 
Staphylococcal enterotoxin detection from Raclette Cheese and Alpine Cheese was 
performed after an extraction step of the VIDAS SET2 instruction. The theoretically 
calculated results are shown in Table 18. 
Table 18.                                                                                                                                
Calculated results after all extraction steps for Raclette Cheese(R) and Alpine Cheese (A) 
Sample # ß(SEA) in TRIS / (ng/mL) 
R1 0,0 
R2 0,0 
R3 12,6 
R4 14,0 
R5 22,9 
R6 25,2 
R7 27,4 
R8 14,8 
R9 25,2 
R10 37,3 
A1 153,7 
A2 165,8 
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Figure 62. Results of the miniVIDAS test with cheese samples 
The effective results are presented in Figure 62. Within this trial, all cheese samples, except 
R1 and 2 which are blanks, are spiked with 25 ng SEA/g cheese. This seems to be a very high 
contamination rate, but it is used here for testing the loss of toxin during the extraction. The 
ISO licensed method miniVIDAS with SET2 is used as determination method to guarantee 
real values with minimal standard deviation. SET2 is based on an ELISA KIT which measures 
the gross toxin content of SEA-SEE in the sample. Only sample R2 has reacted as calculated 
(no SEA spiking), all other samples are tested much lower than the SEA content should be. 
The fact can be monitored with the received recovery rates of SEA, which are much lower 
than expected. This allows the conclusion of toxin loss during the numerous extraction and 
clean-up steps when using cheese samples. Positively, it can be stated, that the toxin can be 
extracted generally. But unfortunately, a minimum of 48% is lost during the way. This 
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extraction method seems to be not applicable for low toxin contents due to the high loss of 
toxin. For improvement of the recovery rate, three possibilities are attractive: increased 
number of repetitions for every extraction step, decreased extraction volumes or application 
of an alternative up-concentration method. The use of Millipore Filter Units (10kDa) instead 
of TCA-Precipitation might keep the activity of the protein and enables increased recovery. 
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6. Surface Plasmon Resonance Experiments including Validation 
In this chapter, an alternative method for the detection of Staphylococcal Enterotoxins was 
tested. Surface Plasmon Resonance was the basic method for this approach. 
 
6.1. Toxin Immobilization Control for the used SAM SPR chips 
High quality SPR chips require reproducible toxin immobilization on the SAM-modified gold 
layers. In Figure 63, the time-dependent immobilization of SEA on a 16-Mercapto-
hexadecanoic acid monolayer-modified gold chip is presented. The immobilization of toxin 
on the monolayer is performed via EDC coupling mechanism. Furthermore, it can be 
monitored (via increasing refractive index n) that EDC not hydrolyzed and so SEA is bound on 
the layer. 
 
Figure 63. Immobilization of SEA on SAM-modified SPR chips via EDC coupling mechanism: 
Change in the refractive index for EDC-immobilized SEA (1-5) on 16-Mercaptohexadecanoic 
acid monolayer-modified gold SPR chips  
The assignment of the chip surface with SEA over time is detectable due to the slowly 
increasing refractive index. This increase is caused by increasing assignment of the surface 
but not by changes in the refractive index of the sample solution, which could be monitored 
by a branch in the progression. The immobilization was successful with this ratio of 
components and could be reproduced. Variations in Dn are caused by changing reactivity of 
EDC and the variying quality of the SAM on the different chips. 
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The results for SEB are analogue and satisfying as well as the ones for SEA (Figure 64). 
 
Figure 64. Immobilization of SEB on SAM-modified SPR chips via EDC coupling mechanism: 
Change in the refractive index for EDC-immobilized SEB (1-5) on 16-Mercaptohexadecanoic 
acid monolayer-modified gold SPR chips 
A proposition of the efficiency of surface coating (occupiancy rate) could be estimated by the 
Langmuir isotherm (Figure 65): 
cK
cK
b
b
×+
××
=
1
maxqq  
 
Figure 65. Calculated Langmuir isotherm for θmax=10, Kb=2 
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SEB3 and SEB4 are additionally blocked with BSA Blocker to prevent unspecific binding after 
toxin immobilization. After immobilization (and blocking), the chips are washed with 140 
mM NaCl solution and the results are compared in Table 19. 
 
Table 19. Change in Dn after the corresponding step compared to the baseline of 140 mM 
NaCl solution 
Trial # Δn / (mRIU) after  
immobilization 
Δn / (mRIU) after 
blocking 
Δn / (mRIU) after  
washing 
SEA 1 3.44 (100%) - 3.1 (90.1%) 
SEA 2 1.85 (100%) - 1.51 (81.6%) 
SEA 3 4.40 (100%) - 4.16 (94.5%) 
SEA 4 2.59 (100%) 3.18 (123%) 2.75 (106%) 
SEA 5 2.83 (100%) 3.45 (122%) 3.11 (110%) 
SEB 1 4.86 (100%) - 4.69 (96.5%) 
SEB 2 4.04 (100%) - 3.72 (92.1%) 
SEB 3 3.95 (100%) 4.37 (111%) 3.92 (99.2%) 
SEB 4 3.39 (100%) 3.66 (108%) 3.21 (94.7%) 
 
A significant increase in the refractive index is measurable, compared to the baseline of the 
140 mM NaCl solution. Due to this, immobilization with EDC seems very effective and 
reproducible. The complete immobilization process is presented in Figure 66. 
 
Figure 66. SEA immobilization (50 mg/L) with BSA-blocking and PBS buffer washing step 
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6.2. Determination of KA(anti-SEA/SEA)  and KA(anti-SEB/SEB) 
A high affinity constant is the key factor for an antibody-antigen-system to be used in a 
sensor system. Herein, the affinity constants of the 2 antibodies, <SEA> and <SEB>, are 
measured twice to guarantee specific and preferably complete binding of the analyte. The 
constant is determined twice for every species. Therefore, four different antibody 
concentrations/ system are measured against PBS buffer.  
Figure 67 and 68 monitor the behavior of the SEA/<SEA> system. 
 
Figure 67.                                                                                                                             
Change in the refractive index during the interaction of <SEA> with the immobilized SEA on 
the chip surface. (ß (<SEA>): (1) 0.75 mg/L, (2) 1.5 mg/L, (3) 3 mg/L, (4) 6 mg/L) 
 
The change in the refractive index corresponds approximately to Langmuir characteristics in 
the time frame from 0 to 20 minutes. Using the highest antibody concentration, the 
saturation region of the Langmuir isotherm is nearly reached, and therefore, the signal is not 
increasing at all. 
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Figure 68. Relative change in the refractive index for different <SEA> concentrations:  
        Immobilization (0-20 min) and washing with PBS buffer (20-30 min) 
                           (ß (<SEA>): (1) 0.75 mg/L, (2) 1.5 mg/L, (3) 3 mg/L, (4) 6 mg/L) 
 
The SEB-<SEB> interaction is characteristically the same (Figure 69 and 70). 
 
Figure 69.                                                                                                                            
Change in the refractive index during the interaction of <SEB> with the immobilized SEB on 
the chip surface. (ß (<SEB>): (1) 0.75 mg/L, (2) 1.5 mg/L, (3) 3 mg/L, (4) 6 mg/L) 
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Figure 70: Relative change in the refractive index for different <SEB> concentrations: 
        Immobilization (0-20 min) and washing with PBS buffer (20-30 min) 
                            (ß (<SEB>): (1) 0.75 mg/L, (2) 1.5 mg/L, (3) 3 mg/L, (4) 6 mg/L) 
 
The values are plotted double-reciprocal and KAs are calculated from the linear slopes with 
the Langmuir equation (Figure 71). The molecular mass of the antibody is calculated with 
150800 g/mol. 
 
Figure 71.                                                                                                                            
Double-reciprocal plot of Dn against c(SEA1) (1), c(SEA2) (2), c(SEB1) (3), c(SEB2) (4) 
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KA was estimated according to the Langmuir model to: 2.1 10
+7 L/mol for <SEA> and 1.6 10+7 
L/mol for <SEB>. Unspecific binding cannot be prevented because it is not guaranted that all 
binding places are occupiued after 20 minutes of toxin immobilization. Therefore, a blocking 
substance, BSA, is used. The blocking step was efficient and successful and kept the change 
in n in the left slope of the angular-dependent SPR signal after antibody addition. 
 
6.3. Determination of Linear Concentration Range and LOD for SEA and SEB in UHT Milk 
Both antibody-toxin pairs exhibit good affinity values and can be applied in a sensor system. 
Firstly, a calibration curve for SEA and SEB in milk is measured. Therefore, UHT milk (3.5 % 
fat) and PBS are mixed in a ratio of 1:1. Toxin concentrations of 25, 50, 100 and 200 ng/ml in 
milk-PBS mixture are proceeded to keep the refractive index in an applicable range. 2 mg/L 
of the appropriate antibody is added to every sample and the sample-antibody mixture is 
incubated for 1 hour following application to the SPR system. The antibody concentration 
was chosen due to its sensitivity the calibration range. The results are presented in Figure 72 
and 73. 
 
Figure 72. Calibration curve for SEA in UHT milk/PBS (1:1) 
Within this experiments, a competitive assay type is used. At 0 ng/mL, the mass of deposited 
antibody on the chip is at its maximum and therefore, the n-value too. The n-value is 
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decreasing with increasing toxin and decreasing antibody concentrations.  
Figure 72 does not include the value for 0ng/mL due to its low precision. 
The limit of detection (LOD) is for SEA is calculated after LOD = yB + 3sB. Herein, 3sB is 
subtracted from the base value, due to the decreasing character of the calibration curve for 
increasing toxin concentrations. The LOD (SEA) is calculated to 6.9 ng/mL. 
 
Figure 73: Calibration curve for SEB in UHT milk/PBS (1:1) 
ß (SEB) = 200 ng/mL was not considered because it was lower than the PBS value. LOD (SEB) 
is calculated to 1.7 ng/mL. The competitive assay type was chosen due to the not 
reproducible immobilization of the antibody as capture layer, its baseline underlies strong 
changes. In addition, the small molecular size of the toxins caused only very small changes in 
the refractive index when binding to the much bigger antibody.  
LODs for SEA and SEB in UHT milk were calculated to 6.9 and 1.7 ng/mL. BIOTRACER 
requirements (linear range of 0.1-10 ng/mL) could be nearly fulfilled for SEB and partly 
fulfilled for SEA by means of this SPR chip arrangement.  
Analogue LOD values for  buffer and milk samples were described by Homola et al. [D1, D2]. 
Improvement of LODs and linear range is achievable with variation of antibody-sample 
incubation time, choice of blocking agent and slight modifications in milk sample 
preparation. A possible modification in sample preparation could be done with a defattening 
step or up-concentration via filtration membrane. This SPR chip system is the preferable 
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analysis method for milk samples after further development steps and is able to reach the 
requirements of the BIOTRACER project completely. In addition, a multi-field SPR chip 
decreases to total analysis time for a larger number of samples. 
Advantages of SPR are online-monitoring of the signal in real time, the ability of achieving 
low LODs with low material input due to circle-flow incubation, label-free detection, easy 
background correction and maintenance of the biological activity of biological material due 
to permanent buffer flow. Disadvantages of SPR are expensive gold chips, prolonged analysis 
time on comparison to the array technique and missing high throughput possibilities 
concerning the number of samples. Advantages of microarrays are cheap chip material, 
shorter reaction times compared to SPR and the ability of scanning large numbers of 
analyses parallely. Disadvantages of the microarray system are the large number of washing 
and drying steps, high intra- and interspot standard deviations, high material input, 
inactivation of biological material due to drying phases, different chip surface preparation 
due to 2D structure and extreme dependence from the quality of biological material and 
dye. 
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7. Experimental Part  
7.1. Materials and Methods 
7.1.1. Materials, Instrumentation and Software 
Chemicals and solvents were purchased from Sigma-Aldrich (Steinheim, Germany), Merck 
(Darmstadt, Germany) and Carl Roth (Karlsruhe, Germany) unless stated otherwise. 
 
Other materials and suppliers are listed as follows (Table 20). 
Table 20. Materials and Suppliers 
Supplier Material 
Toxin Technology (Sarasota, FL, USA) Primary Antibodies against Enterotoxins 
Acris Antibodies GmbH (Herford, Germany) Primary Antibodies against Enterotoxins 
Rockland Immunochemicals, Inc 
(Gilbertsville, PA,USA) 
Secondary Cy3-labeled Antibody against 
rabbit 
Qiagen (Venlo, Netherland)  Antibody against His6, Secondary 
Peroxidase-labeled Antibody, Substrate for 
Peroxidase, Alexa532-labeled Antibody 
against His6 
Sigma-Aldrich (Steinheim, Germany) PBS tablets, Casein 10x Blocker, GPTS, 
APTES, MPTS, Tween 20, Thiols for SPR 
Carl Roth (Karlsruhe, Germany) Roti Nanoquant (5x), BSA 
Pierce (Rockford, IL, USA) Melon Gel Spin Purification Kit, Nab Protein 
A Plus Spin Kit, Zeba Empty Spin Columns, 
Protein-free Blocking buffer, Disuccinimidyl 
suberate (DSS), BCA Assay Reagents 
Schott Nexterion (, Germany) Nexterion Block E, Nexterion Epoxy slides 
ABCR (Karlsruhe, Germany) Aldehyde Silane 
Millipore (Billerica,MA, USA) Amicon Ultra Filter Units 10 kDa (0.5 mL and 
15 mL)  
Whatman (Sanford, USA) Fast Slides, Micro Caster 
Thermo Fisher Scientific 
(Portsmouth, NH, USA) 
Microarray slides with hydrophobic inc 
GE Healthcare (Munich, Germany) Cy3/Cy5 NHS ester, Sephadex G-25/G-15 
Active Motif (Tegernheim, Germany) Chromeo546 NHS ester 
Biomérieux Germany (Nuertingen, 
Germany) 
VIDAS SET2 Kit 
Biochrom (Berlin, Germany) 50 ml Falcon tubes 
Apollo Scientific Limited (Stockport, UK) N-(5-Amino-1-carboxypentyl)iminodiacetic 
acid (NTA) 
Greiner Bio One (Kremsmünster, Austria) 96 and 386 well plates (clear and black, 
round and F-Bottom) 
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Toxins and antibodies were obtained as lyophilized crystalline powders and diluted with 
Millipore water to a final concentration of 2000 mg/L (SEA, SEB, SEC), 1000 mg/L (all 
antibodies) and 500 mg/L (SED, SEH). The structure and spectral data of Chromeo 546 were 
published in [E1]. 
 Instrumentation 
Absorption spectra and data in PMMA cuvettes (1 x 1 x 3 cm) were acquired on a Cary 50 Bio 
UV-visible spectrophotometer from Varian (Palo Alto, CA, USA). Fluorescence spectra and 
data were measured on an Aminco Bowman AB2 luminescence spectrometer (SimAminco, 
Rochester, NY, USA) equipped with a 150-W continuous wave xenon lamp as the excitation 
source. Standard quartz cuvettes were used for all experiments. Absorption data and 
fluorescence emission intensities of solutions in microplates were measured on a Tecan 
GENios Plus microplate reader (Zurich, Switzerland) with ten flashes, respectively.  
Microarrays were read out with different sources: A Tecan LS 200 (Zurich, Switzerland) was 
used at the University Hospital of Regensburg, an Affymetrix 428 Arrayscanner (Santa Clara, 
CA, USA) at the University of Regensburg and an Axon GenePix 4000B Arrayscanner at the 
Austrian Research Center Seibersdorf (Dr. Claudia Preininger, Austria). The Tecan LS 200 
apparatus works with two lasers, at 633 nm and at 532 nm. The dichroic filters were set to 
575 ± 50 nm and 692 ± 45 nm. The Affymetrix 428 works with two lasers, at 532 and 635 nm. 
The filters were set to 570 ± 10 nm and 670 ± 10 nm. The Axon GenePix 4000B works with 
lasers at 532 and 635 nm. The filters were set to 575 ± 17,5 and 670 ± 20.  
Contact angles measurements were done with a tensiometer from Erma (Tokyo, Japan). A 
Schott Blueline pH Meter was used for adjusting the pH of the buffers. A Lab dancer vortexer 
from VWR International (Darmstadt, Germany) and a shaker - Akku-Schüttler (KM - 2 Akku) -
from Edmund Bühler GmbH (Heching, Germany) was used. The protein purification was 
carried out with an Eppendorf centrifuge 5415 R with 45° fixed angled rotor (FA 45-24-11, up 
to 16.000 rcf(g)/13100 rpm). For spotting the Erie microarrays an Eppendorf Research pro 
Electronic Pipette (0.5 - 10 μL) was used, whereas for the FAST slides the MicroCaster hand 
spotting device from Whatman (Sanford, ME, USA) was applied. A m-box from was used as 
humidity chamber for all incubations. Furthermore, all cleaning and blocking steps were 
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carried out in 50 mL falcon tubes from Biochrom (Berlin, Germany). The Biosuplar 6 from 
Mivitec GmbH (Sinzing, Germany) was used for all SPR measurements. 
Several microarray formats were used: 96 well (1.5 mm diameter) glass microarrays with 
hydrophobic patterned wells from Thermo Fisher Scientific (Portsmouth, NH, USA), blank 
glass slides from Menzel-Gläser (Braunschweig, Germany), Nexterion Epoxy slides from 
Schott (Jena, Germany) and the FAST slides from Whatman (Sanford, ME, USA).  
Software 
The data were analyzed with GenePix Pro 6.0 (Molecular Devices, Union City, CA, USA), 
Origin (Microcal, Northampton, MA, USA) and Office 2003/2007 (Microsoft, Redmond, USA).  
 
7.1.2. Gel Filtration and Affinity Chromatography 
Labeled antibody was separated from unlabeled dye by gel permeation chromatography 
using Sephadex G-25 or G-15 from GE Healthcare as stationary phase (placed in a 10 ml Zeba 
Spin Column) and 1 x phosphate-buffered saline (PBS) buffer 10 mM pH 7.4 as eluent. Spin 
columns for Affinity Chromatography from Pierce (Melon Gel Spin Purification Kit and Nab 
Plus Spin Kit) were used as alternative clean-up method. 
 
7.2. Buffer Preparation 
In this chapter, the receipts and preparation guidances of all applied buffers were provided.  
1 x PBS/PBST buffer 
1 x PBS from PBS tablets 
5 tablets are dissolved in 1 L Millipore water and yield 10 mM phosphate buffer, 2.7 mM KCl 
and 137 mM NaCl, pH7.4 at 25°C. 
 
1 x PBS from salts 
8 g NaCl (137 mM), 0,2 g KCl (2.68 mM), 3.63 g Na2HPO4•10 H2O (11.3 mM) and 0.24 g 
KH2PO4 (1.76 mM) are diluted in 1 L Millipore water. The pH is adjusted to 7.4.  
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PBST: 
PBST is a 1 x PBS buffer, pH 7.4 with 0.5 % (w/w) Tween 20. 
 
Bicarbonate buffer (BCB) (basic protocol for pH 8.3) 
2.1 g of NaHCO3 are diluted in 25 mL Millipore water and the pH is adjusted to 8.3 with 1 M 
NaOH. Storage is best at 4° C. 
 
Pierce Protein-free Blocking buffer with Tween 20 
Add 0.5% (w/w) Tween 20 to Pierce Protein-free Blocking buffer to yield a final volume of 1 
L. Store at 4° C. 
 
Casein Blocking buffer for Nitrocellulose slides 
100 mL of 10 x Casein Blocking buffer concentrate (Sigma-Aldrich) are diluted 10 fold. Store 
at 4° C for 4 weeks. 
 
BSA Blocking buffer  
5 g BSA are diluted in 1 x PBS buffer pH 7.4 to a final volume of 100 mL and shaked slowly to 
prevent foam. BSA buffer should always be freshly prepared prior to spotting on 
microarrays. 
 
7.3. Surface Modification for Staphylococcus aureus Enterotoxin Arrays 
Chapter 7.3 is related to the basic construction steps of the developed S. aureus Enterotoxin 
Array. Surface cleaning of the glass slides is performed prior to the silanization process. 
Afterwards, the toxin layer is immobilized on the surface-treated microarray slides following 
blocking of the free binding sites. As a final step, the target molecules are bound on the 
array, which is now ready for read-out. 
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7.3.1. Surface Cleaning 
Untreated slides are cleaned in a 1:1:5-ratio solution of NH3 (20%), H2O2 (30%) and Millipore 
water for 10 minutes at 80° C. The temperature must be reached before adding the slides to 
the purification medium. Afterwards, slides are extempted from residues by shaking in 
Millipore water two times and subsequent drying in an Argon steam.  The cleaning solution 
can be reused up to 3 times. The resulting surface quality was tested with contact angle 
measurement before and after the procedure. This protocol was adapted from the Diploma 
thesis of Michaela Chwala (2007, [E2]). 
 
7.3.2. Silanization 
Silanization process: 
 
Figure 74. Silanization process scheme for glass slides (reproduced from [B17])  
Basic silanization protocol: 
Cleaned slides are silanized under reflux in a 2% (v/v) solution of silane in 200 mL dry toluene 
for 3 h at 115° C (Figure 74). Schlenk flasks are used for this step to guarantee nitrogen 
atmosphere. To remove white silane residues, the slides are swilled in toluene and shaked in 
ethanol (pA) for 5 minutes. Afterwards, the slides are dried in an Argon steam. If silane 
residues are still visible at the glass surface, slides must be cleaned again in ethanol with 
ultrasonification for 1 minute. The resulting surface quality was tested with contact angle 
measurement. 
Several silanization parameters [D3] where tested as presented in Table 21. 
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Table 21. Applied silanization methods and parameters for glass slides 
Method 
# 
Silanization 
agent 
Reaction 
time [h] 
Solvent-Silane 
mixture 
Comments Reference 
A GPTS 3 
no solvent, 
100% silane 
RT, no N2 atmosphere, with 
coverslip, EtOH 
[E5], [E6] 
B GPTS 1 
2,5 % in EtOH 
/13 mM acetic 
acid 
RT, no N2 atmosphere, 
cleaning in EtOH, 
silanization in 50 ml Falcon 
[E4] 
C APTES 2 
no solvent, 
100% silane 
RT, no N2 atmosphere, with 
coverslip, EtOH 
[E5], [E6] 
D APTES 1 
5% in 95/5 (v/v) 
ETOH/H2O 
RT, no N2 atmosphere, 
cleaning in 95/5 (v/v) 
EtOH/H2O, 
silanization in 50 ml Falcon  
[E4] 
E MPTS 1 
1% in EtOH 
/18 mM acetic 
acid 
RT, no N2 atmosphere, 
cleaning in EtOH/18 mM 
Acetic acid, 
silanization in 50 ml Falcon 
[E4] 
F 
Aldehyde 
silane 
2 
no solvent, 
100% silane 
RT, no N2 atmosphere, with 
coverslip, EtOH 
[E5], [E6] 
G 
Aldehyde 
silane 
1 2% in EtOH 
RT, no N2 atmosphere, 
cleaning in EtOH, 
silanization in 50 ml Falcon 
[E4] 
H APTES 3 3% in toluene 
under reflux, N2 atmosphere 
Schlenk flask 
[E7-E9] 
R GPTS 3 2% in toluene 
under reflux, N2 
atmosphere, 
Schlenk flask 
[E1], 
[E7-E9] 
 
 
 
 
7.3.3. Toxin Immobilization on the Array Surface 
3 different slide types were applied: 
1. Homemade silane slides with hydrophobic Teflon inc (2 x 96 wells for 1mL solution) 
2. Plain glass slides with Epoxy silane-coating (Schott Nexterion Slide E) 
3. 3D Nitrocellulose slides (Fast Slides from Whatman) 
Each slide type requires a special protein spotting technique: 
Method #R was now chosen as standard silanization process for all homemade Epoxy 
slides with hydrophobic teflon pattern. 
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1. The homemade slides were spotted with an Electronic Pipette from Eppendorf (0.5-
10 mL volume). 1 mL solution is pipetted in each cavity.  
2. Plain glass slides were spotted with an Electronic Pipette from Eppendorf (0.5-10 mL 
volume) as well. 0.5 mL solution is pipetted per spot.  
3. Nitrocellulose slides were treated with the MicroCaster (Whatman), a hand-arraying 
system especially for Fast slides. Fabrication of this layer is made following the 
MicroCaster protocol [E10]. 
Basic spotting protocol: 
The toxin layer has to be spotted rapidly to prevent dessication and smearing effects on the 
array surface. Following spotting, the array is incubated in a humidity chamber for 1 h at 
room temperature. Afterwards, 2-3 clean-up runs in PBST and one in Millipore water, each 
for 5 minutes are applied. The Argon steam-dried slides can be stored up to one year and are 
best to use after 3 months of storage under vacuum at room temperature. 
The basic spotting protocol is used unless stated otherwise. 
 
7.3.4. Blocking of Free Silane Binding Sites 
3 different blocking modes were applied: 
1. Blocking with coverslip (BSA-PBS blocking buffer) 
2. Blocking in 50 mL Falcon tube (Casein Blocker and Protein-free blocking buffer) 
3. Fast Frame for Fast Slides (all buffers) 
 
Blocking protocol: 
BSA-PBS blocking buffer slides were drained with 1 mL of buffer solution on the surface and 
covered with glass coverslips and put on a rocking plate with gentle agitation. Fast Slides 
were covered with the Fast Frame and 700 mL buffer per field was filled in. They were put on 
the rocking plate as well. All other slides were put in a 50 mL Falcon tube, filled with 40 mL 
of blocking solution and retained on a rocking plate. Following incubation, the slides are 
shaken 2-3 times in PBST and once in Millipore water. Each run lasts 5 minutes. All slides, 
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except the Fast Slides which require nitrogen treating, are dried in an argon steam. Table 22 
depicts the used buffers and their characteristics. 
Table 22. Blocking protocols for different microarray types 
Blocking buffer Buffer preparation Blocking parameters 
Protein-free Blocking buffer Add 5g/L Tween 20 1-2 h at RT 
BSA-PBS buffer 
Add 5 g/L BSA to 1x PBS pH 
7.4 
1-2 h at RT 
Casein Blocker 
(only for Fast Slides) 
Dilute 1:10 with Millipore 
water 
1 h at 37°C 
Block E 
(for Nexterion Slide E) 
Dilute 1:4 with Millipore 
water 
15 min at 50°C 
 
 
7.3.5. Target Incubation 
Preparation of Standards: 
Toxins stock solutions are solved in PBS buffer or either in UHT/raw milk. If milk is used, 1h 
at room temperature and soft shaking is suggested to enable toxin incorporation into the 
matrix. 
 
Antibody Addition: 
Prior to incubation on the array, the pre-concentrated antibody solution is pipetted to the 
standard or sample and incubated with moderate agitation for 1 h at room temperature. 
 
Incubation on the Array: 
If labeled primary antibodies (primary system) against the toxins are utilized, only the first 
incubation step is necessary. For use with a secondary labeled antibody (secondary system), 
the second step is done as well. According to the three slide types, different incubation 
methods are applied according to Table 23. 
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Table 23. Target incubation protocols for different slide types 
Microarray 
format 
Primary system Secondary system 
 Incubation Method 
Incubation 
Condition 
Incubation 
Method 
Incubation 
Condition 
Teflon inc array 
Pipet 1mL of target 
solution in each cavity 
1.5 h, dark, 
humidity 
chamber 
Pipet 1mL of 
target solution in 
each cavity 
1 h, dark, humidity 
chamber 
Plain glass slide 
Pipet 100 mL of target 
solution onto the array 
and cover with second 
slide 
1.5 h, dark, 
humidity 
chamber 
- - 
Nitrocellulose 
slides: 
FASTTM slides 
Fast Frame: 
Affix the frame on the 
slide and fill in 700 mL (1-
pad slide) or 100 mL (16-
pad slide) of target 
solution 
1.5 h, dark, 
Fast Frame 
with plastic 
seal 
- - 
 
After every systems application, the arrays are cleaned by shaking in PBST (2-3 times) and 
water (once), each for 5 minutes. Afterwards, they are dried in an Argon steam. 
 
7.4. Surface Modification for SPR measurements 
Chapter 7.4 describes the basic construction steps of the developed S. aureus Enterotoxin 
Surface Plasmon Resonance Chip. Surface cleaning of the SPR Chips is performed prior to the 
chip modification with self-assembled monolayers. Calibration of the chips with NaCl 
solutions is considered as the next step. Afterwards, the toxin layer is immobilized via EDC 
on the surface-treated SPR chips following blocking of the free binding sites. As a final step, 
the target molecules are bound on the SPR chip. 
 
7.4.1. Cleaning Procedure and Preparation of SAM 
SAMS are formed spontaneously on gold and other metal surfaces via alkanthiol coating. The 
major advantage of the gold surface is given by its stability against most oxidating 
substances. Immediately before use, the chips are cleaned in Ethanol in an ultrasonic bath 
for 20s. Prior to functionalization, the gold surface of the SPR chip is cleaned in Piranha 
solution, a 1:3-mixture of H2O2 (30%) and concentrated H2SO4. Afterwards, the chips are 
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cleaned with ultra-pure water and dried. 16-Mercaptohexadecanoic acid forms a self-
assembling monolayer when incubated as a 20 mM solution (in Ethanol) over night. 
Following SAM attachment, the chips are cleaned in Ethanol again and dried. 
 
7.4.2 Preparation of Working Solutions 
Sodium chloride stock solution and dilutions 
The stock solution is a 600 mM NaCl solution in ultra-pure water. The three NaCl solutions 
(100, 200 and 400 mM) are prepared via dilution of the stock solution with ultra-pure water. 
A 140 mM NaCl solution is prepared from stock for the working buffer and the 
standards/sample dilution. 
Physiological, phosphate-buffered sodium chloride solution (1xPBS pH 7.4) 
The physiological PBS solution (140 mM NaCl, 25mM NaH2PO4, pH 7.4) is made from 
NaH2PO4*2H20 via dilution with the 140 mM NaCl solution. The pH is adjusted to 7.4 with 1 
M HCl. 
EDC-Toxin solution 
2.5 mg EDC, 1.95 mL 140 mM NaCl solution and 50 mL toxin stock solution (2 mg/mL, SEA or 
SEB) are mixed in an Eppendorf Cup. This solution can`t be stored and must always be mixed 
freshly due to the hydrolysis of the EDC. 
BSA Blocking solution 
A 2 mg/mL solution is prepared from ultra-pure BSA and ultra-pure water. 
 
7.4.3. Calibration of the Instrument 
The reflected beam is transferred into an electrical signal by use of a photomultiplier tube. 
The signal change is proportional to the change of the refraction index in the biological layer 
above the gold film. First of all, solutions with known change in reflectance have to be 
measured to transfer the electric signal into a physical value. 
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For this purpose, sodium chloride with concentrations of 100, 200 and 400 mM were used 
and brought into the measuring cell after the following scheme: The cell is filled with 
destilled water and awaited until the signal is constant. Now the sodium chloride with the 
lowest concentration is applied and the signal change is monitored. If the signal seems to be 
stable (10 minutes are applied here), the cell is flushed with destilled water until the signal 
reaches its origin value. Afterwards, the higher concentrations are applied in the same 
manner. Furthermore, the received signal is plotted against the sodium chloride 
concentrations (mM). Supplementary, the refractivites of the NaCl solutions are measured 
with an Abbé refractometer. Now, the signal is plotted against the refraction index. 
Following calibration, a baseline with the 140 mM NaCl solution is made in the same 
manner. 
 
7.4.4. Immobilization of Toxin on the Array and Blocking 
Herein, 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide is used to activate carboxy- and 
amino functions. The reaction is proceeded in 2 steps, activation and immobilization (Figure 
75). Afterwards baseline application, the ECD-toxin solution is applied to the system and 
pumped in circle for 90 minutes. After this procedure, the BSA Blocker is pumped around in 
the system for 30 minutes, followed by a washing step with the 140 mM NaCl solution until 
the signal is constant. The new baseline is done with the PBS buffer. 
 
Figure 75. Protein immobilization with EDC (partially reproduced from [B7]) 
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7.4.5. Determination of the Binding Constants of <SEA> and <SEB> 
A calibration curve is made separately for every antibody type. For every curve, several 
dilutions of the Cy3-labeled <SEA> (or Cy3-labeled <SEB>) are made in PBS buffer within the 
region of 0.75-8 mg/L. Beginning with the lowest antibody concentration, every solution is 
applied to the system for 20 minutes followed by a washing step with PBS buffer. The 
reference channel is measured with PBS. 
 
7.4.6. Measurement of the Real Samples 
To prepare a milk sample, 1 mL UHT milk 3.5% fat and 1 mL toxin solution (SEA or SEB in PBS) 
are mixed and stored at 4° C for 1 h. The toxin concentrations are ranging between 25 and 
200 ng/mL. Following incubation, the labeled antibody is pipetted into the solution for a final 
concentration of 2 mg/L. The toxin-antibody complex in milk is incubated at 4° C for 1 h and 
brought to room temperature for measurement. First, the sample with the highest toxin 
concentration is applied, followed by lower concentrations to guarantee increased binding 
of increased antibody concentrations at lower toxin concentrations. The samples are 
pumped in the system for 20 minutes, followed by a washing step with PBS for 10 minutes. 
During sample measurement, the reference channel is filled with a mixture of milk and PBS 
(1:1). For washing, PBS buffer is used as well as for the measurement channel. 
 
7.5. Labeling and Purification 
 
Figure 76. Labeling for molecules with amino groups (P: protein, F: fluorophore)[B7] 
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Within this chapter, the applied labeling (Figure 76), purification and determination 
techniques for the specific antibodies are described. The first part gives an overview of the 
general labeling procedure for <SEX>. The second part deals with the clean-up of the labeled 
antibodies followed by a description of quantitative protein determination methods. The 
calculation of the Dye-to-Protein and Fluorescence-to-Protein ratio represents the final 
component. 
 
7.5.1. Fluorescent Labeling of GST- and Staphylococcus aureus Enterotoxin Antibodies  
Cy3-NHS ester and Chromeo546-NHS ester are applied as labeling agents [E11, E12]. <GST> 
and <SEX> (X: A, B, C, D and H) are labeled with the Cy3-NHS ester from GE Healthcare 
(Figure 77, Table 24). Alternative labeling experiments were proceeded with the Chromeo 
546-NHS ester from Active Motif (Figure 78, Table 25). 
 
Table 24. Properties of Cy3-NHS ester (adapted from [E11]) 
Dye Cy3 
M / [g/mol] 765,95 ε / [M-1 cm-1] 250000 λabs(max) / [nm] 549 λem(max) / [nm] 562 
 
 
Figure 77. Structure of Cy3-NHS ester (adapted from [E11]) 
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Table 25. Properties of Chromeo-NHS ester (adapted from [E12]) 
Dye Chromeo 
M / [g/mol] 703,82 ε / [M-1 cm-1] 98800 λabs(max) / [nm] 545 λem(max) / [nm] 561 
 
 
Figure 78. Structure of Chromeo 546 NHS ester (adapted from [E12]) 
 
The volume of fluorescent dye which is speifcially used per labeling batch (MR, 
concentrations of dye/protein is calculated by the following equations: 
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Table 26. Labeling trials 
Trial 
# 
pH  
(BCB buffer) 
Reaction 
time (h)/ 
Stopping 
time (h) 
MR Dye 
Protein 
type 
Comment 
1 8.3 1/0.5 
1, 3, 5, 8, 
10, 12, 15, 
18, 20 
Cy3 <GST> MR test 
2 8.3 1/0.25 20 (x3) Cy3 <GST> 
3 clean-up 
methods 
3 8.3 1/0.25 15 (x6) Cy3 <GST> 
5 clean-up 
methods + 
reference 
4 8.3 1/0.5 10, 12, 15 Cy3 <SEA> MR test 
5 
7.5 
7.8 
8.3 
8.7 
8.0 
19/1,25 
19/1.25 
1.75/0.5 
1.75/0.5 
19/1.75 
12 Cy3 <SEB> pH + time test 
6 
7.5 
8.7 
19/1.25 
1.75/0.5 
12 Cy3 <SEA> 
pH + time test, 1 
clean-up method 
7 
7.5 
8.0 
4/0.5 12 Cy3 
<SEA>, 
<SEB> 
pH test, 1 time + 
clean-up method 
8 8.0 3/0.5 12 Cy3 
<SEA>, 
<SEB> 
1 time + clean-up 
method + pH 
9 8.0 1/0.25 12 
Chromeo 
546 
<HSA>, 
<bovIgG> 
 
10 8.0 
2/0.25 
 
2/0.25 
12 
Chromeo 
546 
Cy3 
<SEA>, 
<SEB> 
Dye contest 
11 8.0 3/0.5 12 Cy3 
<SEA>, 
<SEB> 
Acris  
11 8.0 3/0.5 12 Cy3 
<SEA>, 
<SEB>, 
<SEC>, 
<SED>, 
<SEH> 
Toxin Tech 
 
Basic labeling protocol:  
The antibody or protein solutions are re-dissolved or diluted to a protein content of 1 
mg/mL. The dye is reconstituted in DMSO to a final concentration of 10 mg/mL. 10% (v/v) of 
1 M 10 x BCB buffer are pipette to a defined volume of the solution and is followed by 
addition of the calculated fluorescent dye volume. The reaction occurs in 3 h by gentle 
120 
 
shaking in the dark at room temperature. Stopping is done by adding 10% (v/v) of 1.5 M 
NH2OH*HCl for 30 minutes. Purification is proceeded immediately via sephadex column or 
spin column. Several parameters where tested as presented in the following Table 26. The 
following parameters were defined as standards for all array-applicated labeled antibodies: 
 
 
 
 
7.5.2. Purification Techniques: Sephadex Column and Spin Columns 
Sephadex G-25/G-15 medium in Zeba Column [E13] 
Sephadex is delivered as dry powder and must be swollen in separation buffer prior to use. It 
is diluted with 4-6 mL of 1 x PBS buffer of pH 7.4 per gram for 3 h at 20° C or 1 h at 90° C 
under stirring conditions. 10 mL of swollen slurry are filled into the Zeba Column and washed 
with PBS. The sample is gently loaded onto the column resin. 1 x PBS is applied as separation 
buffer and elutes the labeled proteins at low flow rates and without external pressure. 
Otherwise, the resin bed would be destructed. The first band (deep pink) includes the Cy3-
labeled protein. Fractions are collected until the solution is clear (around 8-10 mL) and 
pipetted into Eppendorf cups until further treatment. Store in the dark. 
Millipore Amicon Ultra Filter Unit 10kDa 0.5 mL [E14] 
500 mL of labeled protein solution are filled in the Amicon 10 kDa Filter Unit. Separation of 
unbound dye is proceeded at 1000 rpm for 10 minutes followed by 15 minutes at 2000 rpm. 
The labeled fraction remains in the filter unit and is carefully pipetted into an 0.65 mL 
Eppendorf cup and stored in the dark. 
Melon Gel Spin Purification Kit [E15] 
The Melon Gel IgG Purification System purifies antibodies by removing non-relevant proteins 
under physical pH allowing the antibody to flow through in a mild buffer suitable for storage 
and downstream applications.  
MR: 12 
Reaction time: 1h 
Stopping time: 30 minutes 
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Spin column procedure: 
Melon Gel Support and Purification Buffer are equilibrated to room temperature. 
Furthermore, the support bottle is swirled to obtain an even suspension. 500 mL of slurry are 
dispensed into a Spin Column and placed in a microcentrifuge tube. The uncapped 
column/tube assembly is centrifuged for 1 minute at 6000 rpm (2000-6000 rcf (g)/4600-8000 
rpm recommended), then the spin column is removed and flow-through is discarded. 300 mL 
of Purification Buffer are added and the centrifuge is pulsed for 30 seconds. This wash is 
repeated once. The bottom cap is now placed on the column. The labeled protein sample is 
mixed with 80 mL Binding buffer, added to the column and incubated for 5 minutes at room 
temperature with end-over-end mixing. The bottom cap is removed, the top cap is loosed 
and the column is re-inserted in the collection tube. Centrifuging is done for 1 minute to 
collect the purified antibody in the microcentrifuge tube. After a cleaning step, the gel may 
be regenerated three times without significant loss of selectivity. 
Nab Protein A Plus Spin Kit [E16] 
NAb Spin Kits are convenient for rapid, small-scale affinity purification of antibodies from a 
variety of sample types.  
Spin column procedure:  
Column and buffers are equilibrated to room temperature and the centrifuge is setted to 
7300 rpm (5000 rcf (g)/7300 rpm recommended). The sample is diluted with 80 mL binding 
buffer. Top cap and bottom closure are removed and opened. The column is placed in an 
Eppendorf cup and centrifuged for 1 minute and the flow-through is discarded.  The column 
is equilibrated by adding 400 mL of binding buffer and mixing briefly. Following centrifuging 
and discarding of the flow-through, the column is capped and the sample applied and 
incubated at room temperature for 10 minutes. Caps are loosened and removed and the 
column is centrifuged for 1 minute. This first collection tube contains the non-bound sample 
components. The sample column is transferred to a new collection cup and washed with 400 
mL of binding buffer. Prior to a 1 minute centrifugation, the resin is briefly mixed with the 
sample. Two additional washes are made. 40 mL of neutralization buffer is added to a 
collection cup and the spin column is placed in it. After 1 minute of centrifugation, the 
sample is slided in the cup and neutralized. 
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The immobilized protein column may be used up to 10 times without significant loss in 
binding capacity. 
 
7.5.3. Quantitative Protein Determination in Solution 
Following removal of unbound fluorescence dye from the sample, the protein content has to 
be determined. At the beginning of labeling experiments 4 different methods are used, 
whereas three are photometric ones and one is fluorometric. Photometric approaches are 
based on intrinsic absorbance at 280nm, Bradford assay or BCA assay. Fluorescence intensity 
measurements are applied at 562 nm emission wavelength. Final determinations are always 
performed with the Bradford assay and fluorescence intensity measurements. 
 
Pierce BCA (2, 2’ – bicinchoninic acid) Assay 
Chemicals:  
1. BCA Reagent A (1% Na2BCA in carbonate buffer, pH 11.25) and B (4% CuSO4∙5H2O 
solution) 
2. ultra-pure BSA stock solution (2 mg/mL) 
BCA reagent: Mix Reagent A and B at a ratio of 50:1. The final solution has to be deep green. 
 
Assay protocol: 
BSA standard solutions are diluted from stock (2 mg/mL, Table 27). 
 
Table 27. BSA standards 
Standard / 
(mg/L) 
20 80 100 300 600 800 1000 1500 2000 
BSA stock / 
(mL) 
1 4 5 15 30 40 50 75 100 
PBS / (mL) 99 96 95 85 70 60 50 25 0 
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For Melon Gel samples, 10 mL of eluate is mixed with 90 mL PBS (1:10 dilution) and 
applicated as described below. Sephadex column samples are used without dilution. 100 mL 
of sample (standard or analyte) are pipette into a 2 mL reaction tube. 2 mL of BCA reagent 
are added and vortexed. The samples are incubated for 30 minutes at 37° C following cool-
down to room temperature.  Photometric determination is proceeded at l = 562 nm with 
ultra-pure water as blank value. The assay scheme is presented in Figure 79. 
 
Reaction scheme: 
 
Figure 79. BCA assay scheme (adapted from [E17]) 
 
Bradford Assay 
Chemicals:  
1. Homemade Bradford reagent:  
Coomassie Brilliant Blue G250, Phosphoric acid and Ethanol. 
2. Roti Nanoquant (5-fold) 
3. ultra-pure BSA stock solution (2 mg/mL) 
124 
 
Coomassie solution: 
1. Homemade:  
25 mg Coomassie Brilliant Blue are diluted in 12.5 mL Ethanol and 75 mL of a 
phosphoric acid-water solution (1:3) are added. The stock solution is diluted 1:5 with 
ultra-pure water to obtain the ready-to-use reagent. 
2. Roti Nanoquant: 
Ready-to-use as Coomassie stock solution. The stock solution is diluted 1:5 with ultra-
pure water to obtain the ready-to-use reagent. 
 
Assay protocol for microtiter plates: 
BSA standard solutions are diluted from stock (2 mg/mL, Table 28): 
Table 28. BSA standards 
Standard / 
(mg/L) 
1,25 2,5 5 7,5 10 
BSA stock / 
(ml) 
9 18,5 37,5 56 75 
PBS / (ml) 141 131,5 112,5 94 75 
Well 
complete / 
(ml) 
150 150 150 150 150 
  
BSA-Standards are pipetted in the standard wells according to Table 18. 1 mL of unlabeled 
antibody and 149 mL of PBS are pipette in a separate well for used as protein reference. For 
determination of the analyte, 2 mL of each sample and 148 mL of PBS are prepared in the 
corresponding sample analysis wells. Each standard, reference and analyte is prepared 4-fold 
on the plate. 150 mL of Coomassie solution is added to each well. The read-out is proceeded 
at 590 nm after 10-60 minutes reaction time with PBS-Coommassie as blank. 
The reaction scheme is presented in Figure 80. 
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Reaction scheme: 
 
Figure 80. Bradford reaction scheme (adapted from [E17]) 
 
7.5.4. Determination of the Dye-to-Protein ratio and Fluorescence-to-Protein ratio 
Dye-to-protein ratio: 
First, the absorbance has to be measured in order to calculate the Dye-to-Protein ratio. 
Ideally, the absorbance values reside in a region of 0.1. 
The concentration is calculated using the Lambert-Beer equation:  =   ∗   ´ ∗   
 (   )´ =    ∗    (   ) =   ∗  (   )´ 
A: absorbance; ε: extinction coefficient; d: cuvette length (1cm); DF: dilution factor 
The protein concentration is measured applying the BCA or Bradford assay. Bradford assay 
was setted as standard due to its robustness and compatibility to detergents. Most of the 
protein samples react dissimilarly with the reagents. So, a reference of the protein, the pure 
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protein, with a known concentration has to be codeterminated. Afterwards, absorbance 
values of the analyte measurements have to be corrected. In protein assays, mass 
concentration ß is widely used. To obtain the molar concentration c, the following equation 
1 is used: 
 (       ) =   (       ) (       ) 
 
The Dye-to-Protein ratio is calculated after equation 2:   =   (   ) (       ) 
With respect to fluorescence intensity and self-quenching, best results are attained with 
D/Ps of 1-2. 
 
Fluorescence-to-protein ratio: 
Fluorescence intensities F are measured at 549 nm excitation and 562 nm emission 
wavelength. The Fluorescence-to-Protein ratio is calculated according to equation 3:   =   (       ) (       )  
 
7.6. Milk and Cheese Sample Preparation 
Chapter 7.6 comprises preparation methods for raw milk and raw milk cheese samples. 
 
7.6.1. Preparation of Raw Milk  
Milk: Raw milk samples from Switzerland  
Sample preparation protocol: 
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Figure 81. Sample preparation Flowchart for raw milk 
15 mL of raw milk sample are filled in an Amicon Ultrafiltration device (10 kDa cut-off, 15 
mL) and cooled to 10° C. The spin device is centrifuged for 30 minutes at 10° C and 4000 rpm 
(Figure 81). The solution remaining in the filter unit is the concentrated sample which is 
directly used for all microarray experiments. Preparation data is presented in Table 29. 
 
Table 29.  Sample preparation data 
Sample 
# 
Sample name Spiking 
/ 
(ng/ml) 
Weight before 
centrifugation 
/ (g) 
Weight after 
centrifugation 
/ (g) 
V before 
centrifugation 
/ (mL) 
V after 
centrifugatio 
/ (mL) 
blank Tankmilk 1 blank 
(centrif., 15 ml) 
Neg. tested 
- 14,670 11,700 15 11,750 
1 Tankmilk 12  
(TM12) 
- 1,985 - - - 
2 Tankmilk 1 
(spiked B 4ng/ml 
centrif., V=1 ml) 
(TM1 sp ZV1) 
4 (SEB) 1,006 0,210 1 0,250 
3 Tankmilk 4  
(centrif., V=15 ml) 
(TM4 ZV15) 
- 15,120 11,753 15 11,750 
4 Tankmilk  6  
(centrif., V=15 ml)  
(TM6 ZV15) 
- 15,170 11,700 15 11,750 
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Sample 
# 
Sample name Spiking 
/ 
(ng/ml) 
Weight before 
centrifugation 
/ (g) 
Weight after 
centrifugation 
/ (g) 
V before 
centrifugation 
/ (mL) 
V after 
centrifugation 
/ (mL) 
5 Tankmilk 9  
(centrif., V=15 ml)  
(TM9 ZV15) 
- 14,670 11,200 15 11,250 
6 Tankmilk 12 
(centrif., V=15 ml) 
(TM12 ZV15) 
- 15,180 11,397 15 11,500 
8 Tankmilk 12  
(spiked B 4ng/ml, 
 V=1 ml) 
(TM12sp V1) 
4 (SEB) - - - - 
9 Tankmilk 1  
(spiked B 4ng/ml   
centrif., V=15 ml) 
(TM1 sp ZV15)  
4 (SEB) 14,610 11,210 15 11,250 
10 Tankmilk 12  
(spiked A 4ng/ml, 
centrif., V=1 ml) 
(TM12sp ZV1) 
4 (SEA) 1,036 0,275 1 0,250 
 
7.6.2. Preparation of Raw Milk Cheese  
Cheese types: Raclette Cheese and Alpine Cheese (both 50% FDM) 
Sample preparation protocol: 
 
Figure 82. Sample preparation protocol for semi-hard cheeses 
129 
 
25 g of cheese sample and 250 mL PBS buffer (pH 7.4; T=37°C) were stomachered in a plastic 
bag for 5 minutes. The bag is heat-sealed and an edge is cut off to enable a clean and 
complete transfer of the suspension into a 500 mL Erlenmeyer flask. The suspension is 
incubated in a water bath for 30 minutes at 37° C with gentle agitation. Afterwards, it is 
transferred into a 1 L plastic beaker. The appropriate toxin spiking solution (25 ng SEA/g 
sample, made from stock solution 2 mg/mL) is added and shaked for another 5 minutes at 
37° C in the water bath. The suspension is cooled down to room temperature outside the 
bath. All samples, except number 1 and 2, are spiked with SEA toxin. The milk proteins are 
removed by casein precipitation with concentrated HCl. The pH of the sample is measured, it 
should be around 6-6.5. 5M HCl is added up to a pH value of 3.5-4. Following this, proteins 
should immediately start to precipitate. The sample is transferred into a 500 mL centrifuge 
container and cooled down to 4° C. Centrifuging is done at 4° C and 4000 g for 10 minutes 
following 10 minutes delay time at 4° C. The upper phase is the sample, which is transferred 
to a beaker with the help of a serological pipette. The pH is tested and brought to pH 7.5-8 
with 5 M NaOH. The solution is centrifuged again at 4° C and 4000 g for 10 minutes and 
reposed for another 10 minutes. The upper phase is transferred to a separation funnel and 
100 mL of Heptane (15-25° C) is added. Shaking is done for 5 minutes in the funnel followed 
by centrifuging for 10 minutes at 4° C (4000 g). The bottom phase is the sample phase. The 
volume is transferred to five 50 mL Falcon tube by using a serological pipette. All samples, 
excluding number 1, are proceded with the heptane step. Precipitating of the toxins is done 
by adding 5% of the volume of 90% (w/v) TCA solution (2.5 mL per Falcon tube). Shaking is 
done for 30 minutes at 18-25° C. The sample is centrifuged for 30 minutes at 4000 g and 4° 
C. The supernatant is centrifuged for another 30 minutes. Re-union of the precipitates is 
done followed by solving them in 0.3 M Tris buffer pH 8(8-10 % Volume of the primary 
solution volume). The pH is brought to 7.5-8 with 4 M NaOH. Now, the solution is ready to 
use in experiments (Figure 82). 
Samples R1-10 are originated from Raclette Cheese, the samples A1 and A2 from Alpine 
Cheese. Preparation data is presented in Table 30 and 31. 
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Table 30. Sample clean-up data 
Sample 
# 
m(Sample) 
/ (g) 
m(PBS) 
/ (g) 
 
Stomacher 
/ (min) 
Water 
Bath 
/ (min) 
Cool down 
 to RT 
/ (min) 
SEA? 
 
pH before 
casein 
precipitation; 
centrifugation 
after HCl / (min) 
R1 25,22 253,8 5 30 45 no 3,8-4; 5 
R2 25,13 256,8 5 30 45 no 3,8-4; 15 
R3 25,12 252,4 5 30 45 yes 3,8-4; 20 
R4 25,19 251,5 5 30 45 yes 3,8-4; 20 
R5 25,39 251,3 5 60 45 yes 3,8-4; 10 
R6 24,91 251,1 5 60 45 yes 3,8-4; 10 
R7 26,51 256,7 5 30 45 yes 3,8-4; 10 
R8 24,24 249,7 5 30 45 yes 3,8-4; 10 
R9 24,11 251,3 5 30 45 yes 3,8-4; 10 
R10 31,77 336,7 5 30 45 yes 3,8-4; 10 
A1 25,47 42,25 3 - 30 yes 3,8-4; 30 
A2 26,09 41,65 3 - 30 yes 3,8-4; 30 
  
 
Table 31. Sample precipitation data 
Sample 
# 
# of cycles 
(Heptane);  
Centrifugation 
 / (min) 
TCA  
Precipitation: 
centrifugation 
/ (min) 
SEA 
level 
/ (ng/g) 
V(sample) after 
TRIS addition / 
(mL) 
ß(SEA) in 
TRIS  
/ (ng/mL) 
R1 0; 0 15+23;  0 50 0 
R2 3; 10 30;  0 20 0 
R3 1; 10 2x30;  25,08 50 12,6 
R4 1; 10 2x30;  25,01 45 14 
R5 5 min shaking; 10 90 min shaking; 2x30;  24,81 27,5 22,9 
R6 5 min shaking; 10 90 min shaking; 2x30;  25,29 25 25,2 
R7 5 min shaking; 10 30 min shaking; 2x30;  23,76 23 27,4 
R8 5 min shaking; 10 30 min shaking; 2x30;  25,99 42,5 14,8 
R9 5 min shaking; 10 30 min shaking; 2x30;  26,13 25 25,2 
R10 5 min shaking; 10 30 min shaking; 2x30;  26,44 22,5 37,3 
A1 - 30 min delay time; 30  24,73 4,1 153,65 
  
 
For tests with the VIDAS System, 0.5 mL of the sample was applied to the VIDAS SET2 
reaction stick. 
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8. Summary and Outlook 
8.1. In German  
Im ersten Teil der Arbeit wurde auf Basis der Vorgaben des EU-Projektes „BIOTRACER“ ein 
kompetitiver Mikroarray zur Bestimmung der Staphylococcus aureus Enterotoxine SEA-SED 
und SEH in Milchprodukten entwickelt. Die Fluoreszenzintensität des Farbstoffes Cy3 wurde 
mit Hilfe eines Arrayscanners bei 562 nm Emissionswellenlänge detektiert. Das Ziel, den 
kompetitiven Array im gewünschten dynamischen Bereich von 0,1-10 ng/mL für alle fünf 
Toxintypen zu entwickeln, konnte nicht erreicht werden. Im Rahmen dieser Arbeit stellten 
die relativ unspezifischen Antikörper sowie Probleme bei der Mikroarray-Beschichtung nicht 
lösbare Herausforderungen im gegebenen Zeit- und Finanzerungsrahmen dar. 
Zunächst wurde die bestehende Reinigungsmethode für Glas Slides hinsichtlich ihrer Qualität 
getestet und verschiedene Silanisierungsmethoden appliziert. Mit Hilfe von Fluoreszenz- und 
Kontaktwinkelmessungen an den silanisierten Slides konnte die Qualität als ausreichend für 
den Aufbau des Arrays befunden werden. Um die Bindung zwischen Antikörper und dem 
immobilisierten Toxin quantifizieren zu können, wurden alle Antikörper mit dem 
Fluoreszenzfarbstoff Cy3 markiert. Mehrere Ansätze mit Varianz in pH, molarem Quotienten, 
Aufreinigungsmethode, Alternativfarbstoff und Markierungszeiten wurden durchgeführt, um 
ein optimales Farbstoff-zu-Protein-Verhältnis und damit die beste Fluoreszenzintensität zu 
erhalten. Zur Abtrennung hoher Konzentrationen ungebundenen Farbstoffes wurde das 
Melon Gel Kit als optimal befunden. Erste Versuche zur Belegung der Antigenschicht mit  
Amino-silanisierten Glasslides, Nitrocellulosemembran-basierten Fast Slides und  Epoxy-
silanisierten Glasslides mit hydrophober Maske ergaben gute Ergebnisse für die letzten 
beiden Typen. Die Aminoslides schieden für das weitere Procedere aufgrund des 
umständlichen Handlings und der schlechten Reproduzierbarkeit aus. Auffällig war bei den 
Nitrocellulose Slides das sehr niedrige Signal-zu-Rausch-Verhältnis und der oft sehr hohe 
Hintergrund, der das Scanning und die Auswertung der Slides erheblich erschwerte. Im 
nächsten Schritt sollte für die gegebene Antigenschicht des primären Systems die optimale 
Konzentration an markiertem Primärantikörper ermittelt werden. Dies stellte sich als diffizil 
heraus, da trotz gleicher Optimierungsstrategie die Antikörper extrem unterschiedliche 
Eigenschaften aufwiesen und daher zum Erlangen relativ ähnlicher Intensitäten sehr 
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unterschiedliche Konzentrationen notwendig waren. Einzig die Konzentration für <SEA> und 
<SEB> konnte als gleich angenommen werden, auch auf den Nitrocellulose Slides lies sich 
dies bestätigen. Bedingt durch die Unterschiede in Konzentration und Fluoreszenz-Intensität 
musste für den Array eine Fluoreszenznormierung gemacht werden, die anschließend 
rechnerisch in jeden Array Einzug halten musste. Im nächsten Schritt wurden verschiedene 
Konzentrationsreihen an kompetitiven Toxingehalten und Toxinsorten durchgeführt. Nach 
mehreren Versuchen ergaben sich lineare Bereiche, die allerdings ausserhalb des 
geforderten Bereiches liegen. Immer wieder auffällig sind im primären System bei allen 
Toxinarten und Slidetypen die relativ hohen Standardabweichungen zwischen 15 und 30% 
und die schlechte Reproduzierbarkeit der linearen Bereiche der einzelnen Toxinarten. 
Desweiteren konnte das niedrige Signal-zu-Rausch-Verhältnis und der oft sehr hohe 
Hintergrund bei den Nitrocellulose Slides nicht verbessert werden, was letztendlich zum 
finalen Ausschluss dieses Slide-Typs für weitere Experimente führte. Ergebnisse der 
Kalibrationsreihen in Milch zeigten identische Ergebnisse zu jenen in Puffer, die die Basis für 
den Array bilden. Als Abschluss der Experimente des primären Systems mit markierten 
primären Antikörpern wurde eine Applikation mit realen Proben durchgeführt. Dafür wurde 
unbehandelte und künstlich kontaminierte Rohmilch aus einer Probensammlung in der 
Schweiz verwendet. Prinzipiell, aber nur sehr eingeschränkt,  funktioniert das Arraysystem 
auch mit der Realprobe, zeigt aber wieder die Schwächen des ungenügenden dynamischen 
Bereiches auf. Im Anschluss an die Messungen mit Realproben wurde das erste sekundäre 
System etabliert, in dem die Konzentrationen für Antigen- und Antikörperschicht 
beibehalten wurden, lediglich der markierte Antikörper wurde durch einen  nicht markierten 
ersetzt und die Detektion mittels eines Cy3-gelabelten Sekundärantikörpers durchgeführt. 
Ziel dieses Ersatzes war die Eliminierung der Fluoreszenznormierung, da nur ein 
Sekundärantikörper notwendig ist. Hinsichtlich Intensität und Varianz ergaben sich gute 
Werte für diese System im kompetitiven Test, jedoch war der lineare Bereich wiederholt 
ungenügend. Als nächster Schritt wurde ein weiteres sekundäres System etabliert, jedoch 
mit komplett neuen Konzentrationsparametern in jeder Schicht. Dies führte wiederholt zu 
guten Intensitäts- und Signal-zu-Rausch-Verhältnissen und zu  niedrigeren Fehlern. Jedoch 
ließ sich der dynamische Bereich weiterhin nicht senken. Das primäre und das sekundäre 
System wurden desweiteren auf die Kreuzreaktivität ihrer verwendeten Antikörper getestet. 
Im Falle des Primärsystems ergab sich eine hohe Kreuzreaktivität, die teilweise auch auf die 
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unterschiedlichen Markierungseffizienzen und Intensitäten zurückzuführen ist und auch 
mittels Normierung nicht zu beseitigen war. Im Sekundärsystem waren die 
Kreuzreaktivitäten relativ niedrig, beinahe optimal. Letztendlich ist der dynamische Bereich 
des  Arrays noch in größeren Konzentrationsbereichen als der gewünschte linearen Bereich, 
jedoch ist der Grundstein gelegt und das System bereits an einer Realprobenreihe getestet. 
Im zweiten Teil dieser Arbeit wurde ein Vergleichssensor zur Bestimmung von 
Staphylococcus aureus Enterotoxinen in Milch auf Basis der Oberflächenplasmonenresonanz-
Spektroskopie entwickelt. Durch Aufrtragung einer selbstorganisierenden Monoschicht auf 
der Oberfläche eines mit Gold beschichteten Glaschips konnten die Toxine SEA und SEB  
reproduzierbar immobilisiert und deren Bindung mit den entsprechenden Antikörpern 
charakterisiert werden. Ein kompetitiver Assay aus Toxin und Antikörper, der direkt an der 
Realprobe appliziert wurde, brachte den Zugang zu Kalibiergeraden, mit denen es möglich 
war, den Toxingehalt der Milch direkt zu bestimmen. Weitere Optimierung und 
Untersuchung des Systems erscheint noch nötig. Bis zum jetzigen Zeitpunkt konnte noch 
nicht geklärt werden, wie sich veränderte Monoschichten auf Immobilisierung und 
unspezifische Bindungen auswirken. Beispiel dafür wäre eine Erniedrigung des Anteils der 
Carboxylgruppen und Ersatz derselben durch Hydroxidgruppen. Die Kreuzreaktionen 
verschiedener Antikörper-Toxin-Paare wurden bereits auf dem Array untersucht und im Falle 
eines sekundären Systems für niedrig befunden. Diese Spezifikation müsste noch auf das 
SPR-System übertragen werden, um in Zukunft mehrere Toxine parallel auf einem Chip 
vermessen zu können. Großer Optimierungsbedarf besteht jedoch hinsichtlich des 
Zeitfaktors. Die komplette Toxin-Untersuchung einer Milchprobe benötigt derzeit bei 
vollständig vorbereiteter und kalibrierter Messzelle 50 Minuten inklusive aller 
Waschschritte. Im Vergleich zu konventionellen Methoden wie der ELISA kann zwar 
erheblich Zeit eingespart werden, jedoch ist mit HPLC ein ähnlich schnelles oder schnelleres 
Ergebnis zu erwarten. Ansatzpunkt böte der Versuch, die Anfangssteigung der Kinetikkurven 
mit den Konzentrationen zu koppeln. Die Auswertung der bisherigen Ergebnisse lässt eine 
einfache Abhängigkeit vermuten, welche die Messzeit erheblich reduzieren würde. Kosten-
optimierung kann zusätzlich vorgenommen werden. Derzeit werden alle Immobilisierungen 
mit einer Massenkonzentration von 50 mg/L vorgenommen. Diese könnte möglicherweise 
ohne erhebliche Reaktionszeitverlängerung verringert werden. Zusammenfassend ist zu 
sagen, dass im Zuge dieser Arbeit wichtige Grundsteine für die neu konstruierte spezifische 
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SPR-Sensorplattform der Enterotoxine gelegt wurden, jedoch noch eine Vielzahl an 
Optimierungs- und Variationsmöglichkeiten vorhanden ist. Bemerkenswert ist die 
Vielseitigkeit und Nachweisstärke der SPR-Spektroskopie, die durchaus mit den etablierten 
Methoden der Analytik und Sensorik in Konkurrenz treten kann. 
 
8.2. In English 
In the first part of the work, an array on a competitive assay for the detection of 
Staphylococcus aureus Enterotoxins SEA-SED and SEH in milk products was developed due to 
the regulations of the project “BIOTRACER”. The fluorescence intensity of Cy3 was detected 
with an array scanner at 562 nm emission wavelength. The goal to design the competitive 
array within the desired dynamic range of 0.1-10 ng/mL for all five toxins was not achieved. 
The unspecifity of the available antibodies and problems with the silanization of the array 
depicted permanent challenges within the scope of this research. 
First of all, well-known cleaning methods for glass slide were tested with regard to their 
surface coating quality and different silanization methods were applied. The quality was 
considered as acceptable for array design by means of fluorescence and contact angle 
measurements. All five antibody types were labeled with Cy3 to quantify the binding of 
antibody with immobilized toxin. Multiple labeling experiments with variation in pH, molar 
ratio, cleaning procedure, kind of fluorescence dye and labeling time were proceeded to 
achieve an optimal dye-to-protein ratio and therefore the best fluorescence intensity. The 
Melon Gel Kit was adjudged optimal for the removal of high concentrations of unbound 
fluorescence dye. First trials for antigen occupancy on amino-silanized glass slides, 
nitrocellulose slides and epoxy-silanized glass slides with hydrophobic pattern yielded in 
acceptable results for the last two slide types. Amino slides were eliminated for further 
experiments due to the circumstantial handling and the poor reproducibility of the intensity 
values. The nitrocellulose slides exhibited very poor signal-to-noise ratio and high 
backgrounds which complicated scanning and analysis of the slides extensively. As a next 
step, the optimal concentration of labeled primary antibodies should be identified for the 
antigen layer of a primary system. This can be considered as difficile. Despite to identical 
optimization strategies, the antibodies had extremely differing characteristics and therefore 
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very different antibody concentrations were necessary for reaching similar intensities. Only 
the concentrations for <SEA> and <SEB> were identical, which was proven on Nitrocellulose 
Slides too. Fluorescence normalization was necessary for each array because of the 
disparities in concentration and fluorescence intensity. Furthermore, the normalization had 
to be integrated in all array analyses. As a next step, different competitive concentration 
rows were made for all toxin types and with differing toxin concentrations. Linear 
concentration ranges were achieved after several trials, indeed they are not within the 
requested concentration ranges. Within the primary system there are significant noticeable 
problems for all toxin types and slide types: high standard deviations between 15 and 30%, 
poor reproducibility of the linear ranges of single toxin types, low signal-to-noise ratios and 
often high background when using Fast Slides. These problems could not be overcome, so 
Nitrocellulose Slides were eliminated for further measurements. The results of the 
calibration rows in milk were identically to those in PBS buffer, which build the base of the 
array. An application of real samples was made as closure for the experiments within the 
primary system. Therefore, untreated and artificially contaminated milk samples from 
Switzerland were used. In principle, real samples are applicable to the array system with 
limitations in insufficient linear ranges. Subsequent, a first secondary system was 
established. The given antigen layer and primary antibody concentrations were kept 
constant, only the labeled antibody was changed against an unlabeled one. Detection was 
carried out with a secondary, Cy3-labeled polyclonal antibody. The goal of this step was the 
removal of the necessity of fluorescence normalization. Within competitive tests, proper 
intensity and variance values were achieved, with limitation in the insufficient linear ranges. 
Another secondary system was established, but with completely new parameters for every 
layer. This leaded to acceptable intensities, signal-to-noise ratios and deviations repeatedly. 
However, the linear range could not be decreased either. Furthermore, both system types 
were tested for the cross-reactivity of their antibodies. The primary system exhibits a high 
cross reactivity which could be partially attributed to different labeling efficiencies and 
intensities that were not removable by normalization. The secondary system exhibits 
relatively low and almost optimal cross reactivities. Finally, the array is not ready to achieve 
the desired linear range, but the corner stone is made and the system was already tested 
with real samples. 
136 
 
Second part of this work was the development of a competitive SPR sensor platform for the 
detection of Staphylococcus aureus Enterotoxins in milk. Based on a self-assembling 
monolayer on the gold surface of a SPR chip, SEA and SEB were reproducibly immobilized 
and the interaction with the corresponding antibodies was characterized. A competitive 
assay was used to establish calibration curves in a real sample. Furthermore, it was possible 
to determine the toxin concentration in milk directly. Further optimization and analysis of 
the system seems to be necessary. At the moment, it is not explained, how modified 
monolayers behave with regard to immobilization and unspecific binding. A decreasing 
proportion of carboxyl groups and exchange of them through hydroxyl groups could be an 
example. The cross reaction of different antibody-toxin couples was already tested on the 
array and was proven to be optimal for secondary systems. The specifications have to be 
carried forward to the SPR system to enable multi-toxin measurements on one chip. 
Optimization in time management is advised. Complete toxin detection in milk samples 
takes 50 minutes, including all washing steps and requiring a completely prepared sensor 
chip. Compared to conventional methods like ELISA, SPR seems to be a time-saving method, 
but HPLC is comparably powerful or faster. Coupling of the starting slope of the kinetic curve 
with the concentration could be a starting-point. The analysis of the previous conclusion 
allows suppose of a simple dependency, which could reduce the measuring time. Cost-
optimization could be another point. At the moment, all immobilizations are done with 50 
mg/L. This might be possible with lower concentrations and without enormously prolonged 
reaction time. 
In summary, important mile stones, such as LOD and processing time, for the newly 
developed specific SPR sensor platform of the Enterotoxins are taken as a base herein, but 
further optimization and variation is neccessary. Remarkably, SPR spectroscopy is versatile 
and conformatory and competes with other methods in analytics and sensor technology. 
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